South Dakota State University

Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange
Electronic Theses and Dissertations
2019

Novel Approaches to Evaluate and Enhance Neonatal Calf
Gastrointestinal Health and Development
Fernanda Trindade da Rosa
South Dakota State University

Follow this and additional works at: https://openprairie.sdstate.edu/etd
Part of the Biology Commons, and the Dairy Science Commons

Recommended Citation
Trindade da Rosa, Fernanda, "Novel Approaches to Evaluate and Enhance Neonatal Calf Gastrointestinal
Health and Development" (2019). Electronic Theses and Dissertations. 3646.
https://openprairie.sdstate.edu/etd/3646

This Thesis - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research
Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Electronic Theses
and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange. For more information, please contact michael.biondo@sdstate.edu.

i

NOVEL APPROACHES TO EVALUATE AND ENHANCE NEONATAL CALF
GASTROINTESTINAL HEALTH AND DEVELOPMENT

BY

FERNANDA TRINDADE DA ROSA

A dissertation submitted in partial fulfillment of the requirements for the
Doctor of Philosophy
Major in Biological Sciences
Specialization in Dairy Science
South Dakota State University
2019

ii
DISSERTATION ACCEPTANCE PAGE
Fernanda Trindade da Rosa

This dissertation is approved as a creditable and independent investigation by a candidate
for the Doctor of Philosophy degree and is acceptable for meeting the dissertation
requirements for this degree. Acceptance of this does not imply that the conclusions
reached by the candidate are necessarily the conclusions of the major department.

Johan S. Osorio
Advisor

Date

Vikram Mistry
Department Head

Date

Dean, Graduate School

Date

iii

This Dissertation is dedicated to the memory of my mom Carma Sanguinet Trindade.
Those whom we have loved never really leave us. They live on forever in our hearts and
cast their radiant light onto our every shadow - Sylvana Rossetti.

iv

ACKNOWLEDGMENTS
First and foremost, I would like to express my sincere gratitude to my advisor Dr.
Johan S. Osorio. Thank you for the life-changing opportunity. I would not have
accomplished this if not for his guidance and support. Thank you for believing in my
work and for challenging me when I thought I was not capable of something. Dr. Osorio
is an incredible mentor. I find it hard to describe how much gratitude I feel toward him.
Thank you to Dr. Mistry, Dr. Chase, and Dr. St. Pierre for serving as members of
my graduate committee. Thank you, Dr. Cutler, for accepting to serve on my committee
as the faculty representative. My sincere gratitude to the graduate committee members for
their time and cooperation every time that we had the meetings, for reviewing my plan of
study, dissertation, and for all the valuable suggestions. I greatly appreciate their support
throughout my Doctoral program.
Thank you to the SDSU DRTF farm crew, especially Pete Linke and Melissa
Schmitt for their assistance with the husbandry and care of the calves during the farm
trial, maintaining the facility, and their help whenever I needed to solve issues at the
farm.
Thank you to my fellow graduate students Nathaly Carpinelli and Roshin Mohan
for their helped whenever I called, and Nirosh Senevirathne for the rides to the farm
while I had the calf trial. Additionally, I would like to thank Karla Rodriguez-Hernandez,
alumni from the SDSU Dairy and Food Science Department. Even prior to my arrival at
SDSU Karla helped me through emails, and as soon as I joined SDSU we became great
friends. My gratitude to her for her friendship during this process.

v

To my friends near and far that I call family, thank you for always encouraging
me to be the best that I can be. I cannot cite names here because that would be a long list,
however they know who they are and how much they mean to me. Lovely friends I
would like to express my sincere gratitude to you. This process would not have been
possible without your support.
Last but not least, I would like to thank my mom for all the support she provided
to me. I thank her for the unconditional love and for encouraging me to chase my dreams.
Mom I cannot express how much I love you. Mom you are missed every day.

vi

TABLE OF CONTENTS
LIST OF ABBREVIATIONS ............................................................................................. ix
LIST OF FIGURES ............................................................................................................ xi
LIST OF TABLES ............................................................................................................ xiii
ABSTRACT...................................................................................................................... xiv
INTRODUCTION............................................................................................................. 1
CHAPTER 1. LITERATURE REVIEW ........................................................................ 5
Neonatal health and immunity ..................................................................................... 5
Immune status of the neonatal calf and the impact on health ..................................... 7
Intestinal functionality and integrity ........................................................................... 8
Intestinal structure and immune system ...................................................................... 9
Intestinal permeability ............................................................................................... 11
Neonatal calf microbiota ............................................................................................. 13
RATIONALE AND OBJECTIVES .............................................................................. 17
CHAPTER 2. COMPARATIVE GENE EXPRESSION ANALYSIS ON THE
ENRICHMENT OF POLYMORPHONUCLEAR LEUKOCYTES AND
GASTROINTESTINAL EPITHELIAL CELLS IN FECAL RNA FROM
NONDIARRHEIC NEONATAL DAIRY CALVES ................................................... 19
ABSTRACT ................................................................................................................. 19
INTRODUCTION ....................................................................................................... 20
MATERIALS AND METHODS ............................................................................... 22
Experimental design .................................................................................................. 22
RNA isolation, cDNA synthesis, primer design and evaluation, and quantitative PCR
................................................................................................................................... 22
Statistical analysis ..................................................................................................... 25
CONCLUSIONS ......................................................................................................... 27
Acknowledgments........................................................................................................ 28
CHAPTER 3. COMPARATIVE GENE EXPRESSION ANALYSIS OF
EPITHELIAL CELL MARKERS ACROSS GASTROINTESTINAL TISSUES
AND FECAL RNA ISOLATED FROM DAIRY CALVES ....................................... 32
ABSTRACT ................................................................................................................. 32
INTRODUCTION ....................................................................................................... 33
MATERIALS AND METHODS ............................................................................... 35

vii

Animals and experimental design .............................................................................. 35
Euthanasia and tissue collection ............................................................................... 35
RNA extraction and real-time quantitative PCR ....................................................... 36
Statistical analysis ..................................................................................................... 37
RESULTS AND DISCUSSION.................................................................................. 38
CONCLUSION ............................................................................................................ 43
ACKNOWLEDGMENTS .......................................................................................... 43
CHAPTER 4. EARLY LIFE FECAL MICROBIOTA TRANSPLANTATION
AFFECTS GROWTH PERFORMANCE, CALF SYSTEMIC, AND
POLYMORPHONUCLEAR LEUKOCYTES MRNA INDICATORS OF
INFLAMMATION AND LIVER FUNCTION IN NEONATAL DAIRY CALVES 49
ABSTRACT ................................................................................................................. 49
INTRODUCTION ....................................................................................................... 50
MATERIALS AND METHODS ............................................................................... 52
Experimental design ................................................................................................... 52
Donor Selection and fecal preparation ...................................................................... 52
Pre-trial phase: experimental design ......................................................................... 53
Trial phase: experimental design and fecal microbiota inoculations ......................... 54
Animal measurements ................................................................................................ 55
Blood sample collection ............................................................................................. 55
Blood biomarkers ....................................................................................................... 56
Polymorphonuclear leukocytes (PMNL) isolation...................................................... 56
Viability analysis of PMNL through flow cytometry ................................................. 57
RNA isolation, cDNA synthesis, and Quantitative PCR (qPCR) ................................ 58
Statistical analysis ...................................................................................................... 59
RESULTS......................................................................................................................... 60
Growth performance and health .................................................................................... 60
Blood biomarkers........................................................................................................... 60
PMNL gene expression .................................................................................................. 62
DISCUSSION .................................................................................................................. 62
Animal Performance .................................................................................................. 62
Biomarkers of inflammation and liver function......................................................... 63

viii

PMNL gene expression .............................................................................................. 66
CONCLUSIONS ......................................................................................................... 67
ACKNOWLEDGMENTS .......................................................................................... 67
OVERALL SUMMARY AND CONCLUSION ........................................................... 77
REFERENCES................................................................................................................ 80

ix

LIST OF ABBREVIATIONS
ADG

Average daily gain

AMPs

Antimicrobial proteins

BCS

Body condition score

BW

Body weight

cDNA

Complementary DNA synthesis

CLDN

Claudin

CON

Control

d

Days

DNA

Deoxyribonucleic acid

DRTF

Dairy Research and Training Facility

E. coli

Escherichia coli

EC

Epithelial cells

FABP2

Fatty acid binding protein 2

FMT

Fecal microbiota transplantation

FPT

Failure passive transfer

GEC

Gastrointestinal epithelial cells

GIT

Gastrointestinal tract

IFNG-γ

Interferon gamma

IgA

Immunoglobulin A

IgG

Immunoglobulin G

IL

Interleukin

KRT8

Keratin 8

MPO

Myeloperoxidase

NF-κB

Nuclear factor kappa light chain enhancer of activated B cells

OTUs

Operational taxonomic units

PAMPs

Pathogen associated molecular patterns

PCR

Polymerase chain reaction

x

PMNL

Polymorphonuclear leukocytes

PRRs

Pattern recognition receptors

RBC

Red blood cells

RNA

Ribonucleic acid

RT-qPCR

Quantitative reverse transcription polymerase chain reaction

SDSU

South Dakota State University

TGF-β

Transforming growth factor

TJPs

Tight junction proteins

TLR

Toll-like receptor

TNF-α

Tumor necrosis factor alpha

TRT

Treatment

wk

Week

xi

LIST OF FIGURES
Figure 3.1 Tight junction protein ZO-1 (TJP1), claudin 1 (CLDN1), and claudin 4
(CLDN4) relative mRNA expression (log2 scale) in rumen, gastrointestinal tract tissues,
and in total fecal RNA isolated from Jersey calves with 5 wk of age. ............................. 47
Figure 3.2 Fatty acid binding protein 2 (FABP2) and keratin 8 (KRT8) relative mRNA
expression (log2 scale) in rumen, gastrointestinal tract tissues, and in total fecal RNA
isolated from Jersey calves with 5 wk of age. .................................................................. 48
Figure 4.1 Rectal temperature (°C) after a fecal microbiota transplantation (FMT) within
antibiotic-free milk replacer into neonatal Holstein calves during a pre-trial phase of 4
days………………………………………………………………………………………70
Figure 4.2 Growth performance from birth (week 1 f age) to weaning (7 weeks of age) of
Holstein dairy calves under a conventional nutritional program (Control) or subjected to
five days of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer
from 8 d to 12 days of age……………………………………………………………….71
Figure 4.3 Performance parameters from birth to weaning of Holstein dairy calves under
a conventional nutritional program (Control) or subjected to five days of fecal microbiota
inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 days of age……72
Figure 4.4 Health parameters from birth to weaning of Holstein dairy calves under a
conventional nutritional program (Control) or subjected to five days of fecal microbiota
inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 days of age……73

xii

Figure 4.5 Inflammatory [Haptoglobin and interleukin 1 beta (IL1-β)] and liver function
biomarkers [albumin and paraoxonase) during the neonatal period in Holstein dairy
calves under a conventional nutritional program (Control) or subjected to five days of
fecal microbiota inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12
days of age……………………………………………………………………………….74
Figure 4.6 Expression of genes related to pro-inflammatory signaling cascade (ZBP1,
NFKB1, STAT3) and cell adhesion (SELL) in polymorphonuclear leukocytes (PMNL) of
dairy calves under a conventional nutritional program (Control) or subjected to five days
of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12
days of age……………………………………………………………………………….75
Figure 4.7 Expression of genes associated with pathogen recognition (TLR2 and TLR4)
and pro-inflammatory cytokines (IL1B and IL8) in polymorphonuclear leukocytes
(PMNL) of dairy calves under a conventional nutritional program (Control) or subjected
to five days of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer
from 8 d to 12 days of age……………………………………………………………….76

xiii

LIST OF TABLES
Table 2.1 Messenger RNA expression for specific gene markers for PMNL and GIT
epithelial cells in non-diarrheic neonatal dairy calves. ..................................................... 29
Table 2.2 Slope, coefficient of determination of the standard curve (R2), efficiency of
amplification, and median cycle threshold (Ct) of quantitative reverse transcription PCR.
........................................................................................................................................... 30
Table 3.1 Gene symbol, hybridization position, sequence, and amplicon size of primers
for Bos Taurus used to analyze gene expression. ............................................................. 44
Table 3.2 Sequencing results obtained from qPCR of Bos Taurus specific primers. ....... 45
Table 3.3 Slope, efficiency (E) of amplification, coefficient of determination of the
standard curve (R2), median cycle threshold (Ct) of quantitative reverse-transcription
PCR, and relative mRNA abundance................................................................................ 46
Table 4.1 Genes selected for transcript profiling in bovine polymorphonuclear leukocytes
(PMNL). ............................................................................................................................ 68
Table 4.2 Blood immunometabolic biomarkers during neonatal period in Holstein dairy
calves under a conventional nutritional program (CTR) or subjected to five days of fecal
microbiota inoculations (FMT) within antibiotic-free milk replacer. ................................. 69

xiv

ABSTRACT
NOVEL APPROACHES TO EVALUATE AND ENHANCE NEONATAL
CALF GASTROINTESTINAL HEALTH AND DEVELOPMENT
FERNANDA TRINDADE DA ROSA
2019
Physiological adaptations of the gastrointestinal tract (GIT) epithelial cells as well
as methods to manipulate early life GIT microbiota colonization during the neonatal
stage, is of great importance to the dairy industry. The first objective of this research was
to optimize a method based on evaluation of bovine transcripts in fecal RNA via RTqPCR using L-selectin (SELL) as a marker for polymorphonuclear leukocytes (PMNL),
keratin 8 (KRT8) and fatty acid binding protein 2 (FABP2) for GIT enterocytes, and tight
junctions in fecal RNA and GIT sections in dairy calves. To test the reliability of the fecal
RNA method, fecal and PMNL samples from neonatal calves were used. The expression
of KRT8 was greater in fecal RNA than in PMNL. In contrast, a greater SELL expression
was observed in PMNL. In another study, postmortem GIT and feces samples were
collected from healthy calves for total RNA isolation. Overall, the expression of FABP2
and KRT8 was similar between fecal RNA and the lower GIT. Taken together, these
results provide further evidence that the fecal RNA method can potentially be used as a
tool to evaluate molecular adaptations of the GIT in dairy calves. The second objective
was to evaluate the effects of early life fecal microbiota transplantation (FMT) from
healthy adult donors on health and performance of neonatal dairy calves. To test the
effects of FMT, newborn calves were subjected to 1×/d inoculations with 25 g of fecal

xv

donor material mixed in the milk replacer from 8 to 12 d of age. Results from this study
demonstrated that calves subjected to FMT tended to have greater body weight than
control calves. The liver function marker paraoxonase was greater in the blood of FMT
calves than control at 3wk of age. These results suggest that FMT in neonatal calves has
positive effects not only on growth performance but also in mediating liver function.
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INTRODUCTION
Neonatal dairy calves experience several challenges early in life, including
adaptation to an extrauterine life, where animals have to adapt from an umbilical-nutrient
mode of delivery to ingest milk and food from buckets or bottles, as well as thermoregulate
their own body and being exposed to a new environment loaded with pathogens. After
birth, the gastrointestinal tract (GIT) undergoes morphological and functional
adaptations, which start with the ingestion of colostrum, affecting the gastrointestinal
motility as well as the acquisition of passive immunity (Guilloteau et al., 1997, Blum and
Hammon, 2000). In addition to the gastrointestinal maturation, the calf has to adapt to a
new pathogen-rich environment and has to transition from pre-ruminant to ruminant
during the weaning period. Together, these factors can prone calves to develop diarrhea
due to the absorption of endotoxins from the GIT or the translocation of microbes
(Constable, 2004). Because of these early life challenges neonatal dairy calves have to
overcome, enteric infections are the leading cause of mortality in preweaned dairy calves
in the US (Berchtold, 2009). Additionally, diarrhea is a major cause of economic loss to
dairy producers, including cost of antibiotics, reduced growth, and increased age at first
calving (Windeyer et al., 2014). Fecal score systems are commonly used by researchers
and dairy producers to keep track and identify animals at risk of developing diarrhea.
More sophisticated methods such as microscopy, end-point PCR, and bacterial culturing
have been used to identifying specific strains of infectious pathogens. However, these
analyses lack information on the actual biological adaptations the GIT undergoes during
the onset of diarrhea. The GIT epithelial cells besides the function of absorption of
nutrients, also act as a barrier to harmful pathogens, and the exfoliation of these cells has
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been associated with an intestinal natural turnover process to preserve tissue structure
(Kaeffer, 2011). It has been estimated that in mammals such as humans, 1010 cells are
shed daily from the small intestine (Donovan et al., 2014). Epithelial cells can be isolated
from different body fluids (i.e., urine and feces), which it is a non-invasive technology
that can be used instead of performing tissue biopsies and postmortem tissue analysis
(Kamra et al., 2005).
The high turnover of cells occurring in the small intestine suggests that at least a
small portion of those exfoliated cells are viable for downstream molecular biology
applications. A noninvasive mRNA-based method as a highly sensitive technique was
originally used for detecting molecular biomarkers of colon cancer in rats (Davidson et
al., 1995, Chapkin et al., 1998) and later for intestinal development and function in adult
humans (Davidson et al., 2003, Zhao et al., 2009). This method has been used to study
nutritional regimens in humans, using stool samples to isolate exfoliated cells from the
GIT (Kaeffer et al., 2007), as well as to quantify intestinal gene expression profiles in
developing infants (Chapkin et al., 2010). In the latter, Chapkin et al. (2010) were able to
differentiate between neonates that were breastfed and formula-fed by their different
transcriptomic profiles.
In this context, our group demonstrated that transcriptional changes of the GIT to
inflammatory conditions (e.g., diarrhea) could be evaluated by alternative methods such
as RNA isolated from feces of neonatal dairy calves (Rosa et al., 2018). In that study,
intestinal exfoliated cells in fecal samples of neonatal dairy calves are viable for
downstream molecular applications. The expression of genes related to inflammatory
pathways as well as cell membrane transporters detected in the fecal RNA was associated
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with blood biomarkers of inflammation at the time point where the calves had the greatest
fecal score (i.e., scours). However, the possibility to use the above method to investigate
intestinal gene expression alterations in dairy calves needed further insights and
evaluation.
The GIT microbial colonization and symbiosis are essential for the development
and physiology of mammals, including neonatal calves (Alipour et al., 2018). The GIT
microbiota has several roles in nutrition, energy metabolism, host defense, and immune
system development. Several factors can potentially affect the newborn intestinal microbial
complexity and maturation including intrauterine environment (i.e., maternal microbiome),
dystocia as well as postnatal factors including environment, diet, antibiotic use, and in the
case of neonatal calves colostrum intake and quality (Oikonomou et al., 2013, PerezMuñoz et al., 2017). Taken together, these several factors suggest that early life
interventions on the gut microbiota can be a key factor in manipulating GIT colonization in
neonatal calves, and therefore improve their health and growth by reducing the
susceptibility to enteric infections. For instance, fecal microbiota transplantation (FMT),
which is the transfer of microbiota via inoculation (i.e., oral administration, endoscopy,
colonoscopy) present in the fecal material of a healthy-selected donor into a recipient, can
potentially restore or shift the GIT microbial composition (de Groot et al., 2017). In human
medicine, FMT has been extensively used to treat individuals suffering from different types
of infections, including inflammatory bowel disease (Ponte et al., 2015, Khanna et al.,
2017). However, in the animal production, there are still many gaps in knowledge when it
comes to utilizing FMT in livestock animals, where very few studies have been conducted,
primarily in companion animals (Pereira et al., 2018), neonatal piglets (Hu et al., 2018b),
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and broiler chickens (Siegerstetter et al., 2018); however, to date, there are no studies that
performed FMT in dairy calves.
The two overall goals of this research are to further validate and optimize a noninvasive fecal RNA method to investigate transcriptomic changes in the GIT neonatal
calves, and to evaluate the effects of an early life fecal microbiota transplant on growth and
health performance of neonatal dairy calves.
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CHAPTER 1. LITERATURE REVIEW
Neonatal health and immunity
In dairy calf development, a major focus of research has been the maturation of
the rumen (Baldwin et al., 2004). However, there is a critical period prior to the solid feed
intake, and consequently, the rumen development and maturation, that is characterized by
high susceptibility to disease. In this period, the gastrointestinal tract undergoes several
changes such as an increase in permeability and functionality (Steele et al., 2016b). The
newborn calf has to adapt its digestive system from an umbilical nutrient delivery during
the fetal period to ingestion of bottle- or bucket-fed milk. After birth, the GIT undergoes
morphological and functional adaptations, which start with the ingestion of colostrum,
affecting the gastrointestinal motility as well as the acquisition of the passive immunity
(Guilloteau et al., 1997, Blum and Hammon, 2000). In addition to the gastrointestinal
maturation, the calf has to adapt to a new environment, which is loaded with pathogens,
thermoregulate its own body, and transition from pre-ruminant to ruminant during the
weaning period. After birth, both microbial and gastrointestinal epithelial cells (GEC)
maturation are influenced by many factors, including diet, length of gestation, and
antibiotic usage. The latter has been closely associated with a fundamental disruption of
the normal intestinal flora (i.e., dysbiosis), and consequently, linked with diseases in both
humans and animals (Francino, 2015). Besides the several challenges described above
that a newborn calf goes through during the first 4 weeks of life, factors affecting early
colonization of the neonate microbiome can fundamentally challenge infants and put
them at risk for immune and metabolic disorders. In newborn calves, intestinal disorders
are common events during the neonatal stage (from birth to weaning), as well as, during
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the preweaning and weaning period leading to diarrhea or calf scour, which is the leading
cause of mortality in neonatal dairy calves in US during the first 4 weeks of life
(Berchtold, 2009). Indeed, according to the National Animal Health Monitoring System
(NAHMS), scours or other digestive problems during the pre-weaning stage account for
57% of calf mortality in the US. Additionally, diarrhea is a major cause of economic loss
to dairy producers, including the cost of antibiotics, reduced growth, and increased age at
first calving (Windeyer et al., 2014). Furthermore, NAHMS also reported high antibiotic
usage for the treatment of calf scours.
Neonatal calf scours are frequently observed from 3 to 21 d of age, but its onset
and duration are determined by the number of pathogens involved and the immune
condition of the animal (Blum, 2006). In mild-diarrhea conditions, loss of extracellular
fluids and electrolytes can take place; however, during severe diarrhea conditions, body
weight loss due to dehydration and cellular damage of the GIT epithelium due to
inflammation can be observed (Blum and Hammon, 2000). The major pathogens that
have been identified as contributing to enteric challenge in calves and consequently, to
the development of calf diarrhea include Escherichia coli K99 (E. coli), Rotavirus,
Coronavirus, Salmonella spp., and Cryptosporidium parvum (Izzo et al., 2011, Cho and
Yoon, 2014).
All these events during the neonatal stage of calves are regulated by an interaction
between infectious pathogens, the immune status of the calf, and the environment.
Despite major advances in dairy calf rearing, the neonatal development has many gaps in
the understanding of the transitional fetal/neonatal physiology, and the transition from
pre-ruminant to ruminant. For most dairy operations, calves represent the next generation
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of milk producing animals. However, keeping young calves healthy and growing is a
complex task. Therefore, understanding these physiological changes and the
transcriptional alterations involved within the gastrointestinal tract that might cause or
induce inflammation, which can affect the animal systemically can be used as a tool to
strategically intervein and manipulate the gastrointestinal tract of dairy calves during the
susceptible period from birth to weaning resulting in health improvement and
productivity.
Immune status of the neonatal calf and the impact on health
The immune status of neonatal calves can be characterized as dysfunctional.
Although all essential immune components are present in neonates at birth, many of the
components are not functional until calves are at least 2 to 4 weeks of age and might
continue to develop until puberty (Chase et al., 2008).
In bovine, since antibodies don’t cross the placenta (Peter, 2013), the
immunoglobulins (IgG) transferred from the cow to the calf through the colostrum are
essential for the newborn’s survival by providing the passive immunity. Poor
immunoglobulin transfer is called failure of passive transfer (FPT) and is linked to
increased neonatal morbidity and mortality in dairy calves (Torsein et al., 2011). The
absorption of intact macromolecules across the intestinal epithelium into the neonatal
circulation is possible for approximately 24 hours after birth (Arthington et al., 2000).
There is evidence that around 12 h after birth, the intestinal enzyme secretion starts to
increase, in addition to the intestinal cell turnover, which reduces the IgG absorption
(Quigley and Drewry, 1998). However, there is a gap between the passive immunity
provided by colostrum and the acquisition of the neonate active immunity. Considering
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that passive immunity acquired from colostrum remains active only up to approximately
21 days of age, the neonatal stage encompasses a wide window of high susceptibility to
infections and illness, and consequently immune challenges (Kampen et al., 2006,
Ranade et al., 2014).
At birth, neonates have neutrophil and macrophage (innate immune cells) activity
reduced, which improves after colostrum ingestion due to the maternal transfer of
immunoglobulins, immune cells, and cytokines. On the other hand, maternal immunity
interference is a challenge regarding vaccine development for neonatal calves. Several
maternal antibodies have a half-life of 28 days (Fulton et al., 2004), therefore the timing
for administrating a parenteral vaccine needs to take in consideration the timeframe
where the maternal antibody is in a low level to produce an immune response to the
vaccine (Cortese, 2009). Additionally, the cow production of estrogen and cortisol prior
to parturition can affect the immune response of the newborn calf by suppressing the cellmediated response (Chase et al., 2008).
Intestinal functionality and integrity

The GIT is a dynamic and complex environment with a microbiologically active
ecosystem (i.e., microbiota) and a heightened immune activity comprising nonhematopoietic (e.g., epithelia, Paneth cells, goblet cells, etc.) and hemopoietic cells (e.g.,
macrophages, dendritic cells, T-cells, etc.) (Maldonado Galdeano et al., 2019).
The small intestine encompasses a dual function: a) provide selective absorption
of nutrients; b) provide a barrier against harmful pathogens within the intestinal lumen
(Yu et al., 2012). The intestinal microbiota does not interact directly with the intestinal
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epithelial cells; however, the feed intake, the host-microbiota, and the host mucosa
interact with each other supporting the health of the GIT tract, and consequently the
animal growth and performance. Celi et al. (2017) defined the gastrointestinal
functionality as a state where diet, effective digestion and absorption, stable microbiota,
effective immune system, intestinal mucosa, and neuroendocrine function of the GIT
interact in a symbiotic equilibrium maintaining the GIT homeostasis and constraining
intestinal dysfunction. Thus, intestinal permeability and GIT barrier play a crucial role in
the GIT physiology and overall gut health.
Intestinal structure and immune system
The intestinal epithelium exhibits numerous physical adaptations to separate the
host connective tissue from the external environment (Guilloteau et al., 1997). Four
important cell types are defined, namely absorptive (enterocytes in the small intestine,
and colonocytes in the large intestine), muco-secreting cells (goblet cells),
enteroendocrine (function in peptide hormone secretion), and Paneth cells (secretory
granules). Under healthy conditions, the renewal of these cells within the GIT occurs
every 2-7 days by the GIT stem cells localized in the crypt base of the GIT epithelium,
however during tissue damage period, the epithelial shed increases (Brittan and Wright,
2004).
Small intestinal absorptive cells (enterocytes) are columnar epithelial cells, which
form crypts and villi to increase surface area for absorption (Steele et al., 2016a). the
mucosal epithelium consists in a mucus-glycocalyx layer protecting the enterocytes,
which is in continuous contact with commensal and harmful microorganisms, this mucus
layer is produced by the goblet cells (mucus-secreting cells), serving as a physical barrier
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(Peterson and Artis, 2014). Intestinal epithelial cells are covered with two layers of
mucus, the firmly adherent layer that is closest to the epithelium and the loosely adherent
layer that is the outer layer (Steele et al., 2016a). The mucus layer is predominantly
mucin-rich layer, whereas the mucin 2 (MUC2) produced by the goblet cells is the most
abundant mucin in the mammalian intestine (Chen et al., 2015). Intestinal epithelial cells
also produce antimicrobial proteins, called AMPs, and secrete them into the mucus layer.
The AMPs produced by these cells include the lysozyme, which breaks down cell wall
components, lactoferrin, which sequesters iron needed for bacterial growth, and alphadefensins when exposed to bacterial products. (Gassler, 2017). In addition to the AMPs in
the mucus layer, secreted immunoglobulin A (IgA) antibodies produced by B cells in the
Peyer’s patches and throughout the intestinal lamina propria are actively transported and
translocated by polymeric immunoglobulin receptor (pIgR) located on the basolateral
membrane of enterocytes. The IgA is then transported through the enterocytes, where the
pIgR is converted into the secretory piece and added to the dimeric IgA prior to secretion
into the intestinal lumen. The secretory IgA limits the association of pathogens with the
intestinal epithelia. The IgA antibody is a major functional component of the humoral
adaptive immune system, specifically at mucosal sites. The antibodies are predominantly
produced in the intestinal lamina propria by plasma cells following B cell differentiation
(Chase and Kaushik, 2019). Also, the commensal microbiota present in the GIT is
essential for the mucus layer integrity, including the thickness of the mucosal barrier as
well as the mucosal interaction with the host-microbiota, which stimulates a state of
inflammatory recognition needed for the maintenance of the intestinal homeostasis
(Galdeano and Perdigon, 2004).
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The enterocytes are the most abundant epithelial cells type lining the
gastrointestinal tract with the primary function of nutrient absorption through active and
passive transport and brush border enzyme activity (Peterson and Artis, 2014). However,
these cells express toll-like receptors (TLR) in their membrane by which upon pathogen
recognition can initiate a pro-inflammatory response in the GIT by producing specific
cytokines. In the case of neonates, the intestinal enterocytes are immature at birth and
mature within the first week after birth, as indicated by the loss of vacuoles along the
proximal-distal axis, which contributes to intestinal barrier closure (Prgomet et al., 2007).
Enteroendocrine cells link central and enteric neuro-endocrine systems through
the secretion of peptides hormones that act locally on the nervous system of the intestinal
lining. Such secretion regulates food intake, GIT motility, and glucose metabolism (Cani
et al., 2013). Beneath the basolateral surface of the GIT epithelium, there is the lamina
propria surface, which hosts immune cells such as macrophages, natural killer cells, mast
cells, dendritic cells, as well as, B cells and T regulatory cells (Chase and Kaushik, 2019).
Intestinal permeability
The establishment of an epithelial barrier requires the formation of
morphologically distinct tight junctions. Tight junctions are adhesive junctional protein
complexes between epithelial cells that connect each other, forming a paracellular barrier,
which facilitates the passage of ions and solutes through the intercellular space while
preventing the translocation of luminal antigens, microorganisms, and toxins (Bischoff et
al., 2014). Tight junctions determine the extent and maintain distinct apical and
basolateral membrane domains in epithelial cells, thereby tightening and maintaining the
permeability capacity of the intestine (Fanning et al., 1998). Tight junctions are crucial
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for the integrity of the epithelial barrier function. Among the tight junction proteins
families, there are 3 transmembrane proteins: occludin, claudin, and junctional adhesion
molecules (JAM). Tight junction protein ZO-1, claudin 1, and 4 are commonly abundant
in the epithelial cell layers (Kiuchi-Saishin et al., 2002, Langbein et al., 2002). When the
claudin-1 gene was knocked out, the epidermal barrier failed to prevent water loss
(Furuse et al., 2002). Pro-inflammatory cytokines such as TNF-α (tumor necrosis factorα) and IFN-γ (interferon-γ) cause disruption of the tight junction barrier resulting in
increased paracellular permeability in intestinal monolayers (Al-Sadi et al., 2009). Antiinflammatory cytokines such as IL-10 (interleukin-10) and TGF-β (transforming growth
factor) maintain tight junction integrity function (Forsyth et al., 2007). Inflammation
associated with gastrointestinal disorders is the major inducer of tight junction
dysregulation, resulting in increased intestinal permeability (Kvidera et al., 2017).
Pathogenic recognition in the intestinal epithelium and signaling response
The intestinal immune system has the ability to distinguish between inducing
either immune responses against harmful antigens or tolerogenic responses towards
antigens derived from nutrients and beneficial bacteria (Maynard et al., 2012). However,
when the mucosal barrier becomes disrupted, bacteria and/or bacterial products can
invade the adjacent tissues and are sensed by antigen-presenting cells, such as dendritic
cells and macrophages. These cells migrate to the lymphoid follicles in the Peyer’s
patches or to gut-draining mesenteric lymph nodes, where they present the antigens to
naive T cells leading to their activation and expansion. The resulting effector T cells
eventually exit the mesenteric lymph nodes and migrate to the gut interstitium (Antoni et
al., 2014). Once in the intestinal lamina propria, they re-encounter their specific antigen
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presented by antigen-presenting cells, which initiates a rapid inflammatory response with
the production of proinflammatory cytokines.
Although commensal microbiota is essential for immunological tolerance, the
immune system needs to differentiate between commensal bacteria and pathogenic
bacteria. Therefore, receptors present in the membrane of epithelial and lymphoid cells of
the small intestine regulates this differential recognition. These receptors have been
named pattern recognition receptors (PRRs), and the structures they sense are termed
pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns
(DAMPs). Several classes of PRRs have been described, including toll-like receptors
(TLRs) and C-type lectin receptors (CLRs) (Brubaker et al., 2015). Under noninflammatory conditions, TLR signaling leads to tolerance towards luminal pathogens
through the down-regulation of pattern-recognition receptors and promotes mucosal
wound healing (Abreu, 2010). When intestinal macrophages and dendritic cells sense
PAMPs, pathogen signaling pathways including the nuclear factor kappa light chain
enhancer of activated B cells (NF-κB) are activated inducing pro-inflammatory cytokines
production such as interleukin 1 (IL1), interleukin 6 (IL6) and tumor necrosis factor alpha
(TNFA), and chemokines, such as interleukin 8 (IL8) (Ceciliani et al., 2012).
Neonatal calf microbiota
Early neonatal GIT microbiome colonization and development begins with
maternal microbiome seeding begins before parturition. The traditional “paradigm” that
the fetus develops in a sterile environment has been challenged in the past years (Aagaard
et al., 2014). 16S ribosomal RNA sequencing demonstrated that bacterial species from
the phyla Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, and Fusobacteria were
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found to exist within the human placental basal plate (an area once thought to be sterile)
(Aagaard et al. 2014). In another study, cesarean-born babies deprived of maternal
vaginal microbial transfer at birth are predisposed to have health issues (DominguezBello et al., 2010).
GIT microbial colonization in a newborn calf includes the vaginal microbiome
and the proximity of the birth canal (Oikonomou et al., 2013). Colostrum and milk
microbiota may also inﬂuence such colonization. Microbial diversity increases with
growth, age, and dietary adaptations in calves (Malmuthuge and Guan 2017).
Lower gastrointestinal tract microbial colonization: Mayer et al. (2012) attempted
to investigate first colonizers in newborn calves; however, this study was not able to
validate such findings in the meconium samples with placental transfer, but the microbial
composition identified was associated with the rectal bacterial flora of the dam. In
another study to investigate the initial colonization of GIT of newborn calf (Klein-Jöbstl
et al. 2019) demonstrated that Proteobacteria were the most abundant in calf feces over
time. However, a significant shift in the microbial composition was observed during the
first 48 hours after birth, whereas Actinobacteria and Bacteroidetes decreased within 12
hours after birth, while Proteobacteria and Firmicutes increased from 24 to 48 hours
after birth. Furthermore, the same study showed the presence of operational taxonomic
units (OTUs) with E. coli in all the fecal samples during all the time points, which is in
agreement with previous studies that demonstrated E. coli colonization in the calf rectum
24 hours after birth (Alipour et al., 2018).
Most of the intestinal microbiota studies in neonatal calves have focused on
identify and classify the fecal microbiota as a representative population of the GIT
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microbiota (Meale et al., 2017a). The microbial population in the gastrointestinal tract of
neonatal calves is primarily important for the stimulation of the inflammatory mechanism
within the intestinal lumen, as discussed previously. The bacteria composition throughout
the GIT (i.e., rumen, jejunum, ileum, cecum, and colon) in neonatal bull calves (i.e., 3 wk
of age) varied in bacterial composition depending on the region, whereas ruminal
samples and large intestine had high levels of Bacteroidetes while the small intestine had
high levels of Firmicutes.
Forestomach microbial colonization: The majority of the microbial investigations
on the forestomach of calves have been focused on the rumen maturation rather than
omasum and abomasum evaluation. The rumen colonization of calves (pre-ruminant) is
mainly colonized by anaerobic bacteria by the second day of life, and the cellulolytic
bacteria population reported to be stabilized within the first week of life. The early rumen
bacterial species consist of the genera Propionibacterium, Clostridium,
Peptostreptococcus, and Bifidobacterium, while Ruminococcus species dominated the
cellulolytic bacterial population (Malmuthuge et al., 2015) . Additionally, bacteria that
are essential for mature rumen function such as methanogens, fibrolytic bacteria, or
Proteobacteria have been detected as early as 20 minutes after birth (Guzman et al.,
2015), and 24 hours after birth, prior to any ingestion of solid feed (Jami et al., 2013).
The findings with rumen microbial colonization in neonatal calves suggest that not only
is early microbiota colonization essential for the rumen development but might also play
a role in microbial metabolic products involved in the early immune development (Li et
al., 2012). This also raised the need to investigate further if such inoculations could be
associated with prenatal exposure, including maternal microbiome (Meale et al., 2017a).
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Collectively, these studies and findings suggested that microbial diversity
throughout the GIT of calves is affected during the preweaning period and can be
partially attributed to the increase in solid feed intake. However, the incidence of
infectious disease during the first 4 wk of life and the use of antibiotics for treatment of
calf diarrhea were also associated with microbial shift (i.e., reduced microbial diversity in
calves with scours) (Meale et al., 2016, Meale et al., 2017b).
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RATIONALE AND OBJECTIVES

The overall goal of this project was to improve the understanding of the
physiological and transcriptional alterations in the gastrointestinal tract (GIT) of dairy
calves during the most susceptible period for enteric infections, the neonatal stage. To
evaluate calf neonatal overall health status and performance, we attempted to validate and
optimized two approaches: a) fecal RNA as a non-invasive technique to study
transcriptional changes in the gastrointestinal tract of dairy calves during healthy and
inflammatory conditions; b) fecal microbiota transplant (FMT) as a tool for microbiota
manipulation in neonatal calves.
Rosa et al. (2018) was the first attempt to utilize the fecal RNA method to
evaluate biological adaptations of the gastrointestinal tract of dairy calves through gene
expression analysis. However, a limitation in this study is the current lack of data
indicating how the transcriptomic profile observed in fecal RNA mirrors that in specific
sections of the GIT. Additionally, fecal RNA isolation remains a challenge due to the
potential enrichment of bacterial RNA and ribosomal RNA, which can create a dilution
effect on the targeted eukaryotic RNA and consequently dampened the sensitivity of the
fecal RNA method. Therefore, the objectives of our research on this topic regarding to
the fecal RNA as a non-invasive method to investigate GIT adaptations study were: 1) to
evaluate the potential enrichment of immune cells and GIT epithelial cells measured
through the transcription of target genes for both immune and epithelial cells in RNA
isolated from fecal samples compared with RNA isolated from blood polymorphonuclear
lymphocytes of neonatal dairy calves; 2) to compare the transcription of gene markers for
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GIT epithelial cells, fatty acid binding protein 2 (FABP2) and cytokeratin 8 (KRT8) in
fecal RNA against several GIT sections in dairy calves.
The intestinal microbiota plays an important role in animal health. An imbalance
in the GIT microbiota can make animals more prone to develop diarrhea and other
diseases. The use of the fecal microbiota transplantation method in a controlled clinical
trial was first reported in 2013 to be an effective treatment for Clostridium difficile
infection in humans (van Nood et al., 2013). To our knowledge, the fecal microbiota
transplantation has not been performed or validated in neonatal dairy calves previously.
Therefore, we aimed to perform a fecal microbiota transplantation in neonatal dairy
calves and to evaluate the effects on health parameters, including inflammatory biomarkers
and overall animal growth.
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CHAPTER 2. COMPARATIVE GENE EXPRESSION ANALYSIS ON THE
ENRICHMENT OF POLYMORPHONUCLEAR LEUKOCYTES AND
GASTROINTESTINAL EPITHELIAL CELLS IN FECAL RNA FROM
NONDIARRHEIC NEONATAL DAIRY CALVES

This chapter was published as: Rosa, F., and Osorio, J.S. 2019. Comparative gene
expression analysis on the enrichment of polymorphonuclear leukocytes and
gastrointestinal epithelial cells in fecal RNA from nondiarrheic neonatal dairy calves. J.
Dairy Sci. 102(8):7464-7468. https://doi.org/10.3168/jds.2018-16074.

ABSTRACT
Increased understanding of the biology of the gastrointestinal tract (GIT) in
neonatal dairy calves during their adaptation to an extrauterine environment will decrease
health problems such as diarrhea while increasing feed efficiency and average daily gain
in preweaned dairy calves. Within this context, a noninvasive method, based on fecal
RNA, to study the GIT in neonatal dairy calves through the isolation of RNA from fecal
samples for quantitative reverse-transcription PCR analysis can provide valuable
information on GIT biological adaptations during the preweaning period. We aimed to
evaluate the potential enrichment of RNA from immune cells or GIT epithelial cells
during fecal RNA isolation. Eight neonatal Holstein calves less than 3 wk old (14.9 ± 5.5
d of age at sampling ± SD) and a fecal score of 2.0 ± 0.7 (mean ± standard deviation)
were used. During a single sampling, fecal and blood samples were taken simultaneously
from each calf before the morning feeding. Fecal samples were immediately frozen in
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liquid nitrogen until RNA isolation, whereas polymorphonuclear leukocytes (PMN) were
isolated from blood samples before RNA isolation. A quantitative reverse-transcription
PCR analysis was performed using a single standard curve composited of equal amounts
of all samples including cDNA from fecal and PMN. The genes myeloperoxidase (MPO)
and L-selectin (SELL) were selected for their specific known function in PMN, whereas
keratin 8 (KRT8) and aquaporin 3 (AQP3) have been associated with epithelial
enterocytes. Our results showed a contrasting gene expression profile between PMN and
fecal RNA; whereas greater mRNA expression of SELL was observed in PMN, a greater
KRT8 expression was observed in fecal RNA. The mRNA expression of AQP3 tended to
be greater in PMN than fecal RNA. Additionally, MPO was not amplified in fecal RNA.
Our findings suggest that under nondiarrheic conditions RNA isolated from stool samples
of neonatal dairy calves will have a considerable number of GIT epithelial cells, which
confirms the reliability of this method under these conditions. However, further research
needs to be done to determine if the same effects are observed during diarrhea or
throughout the preweaning period of dairy calves.
Key words: Fecal RNA, gene expression, polymorphonuclear leukocytes, dairy calf
INTRODUCTION
The gastrointestinal tract (GIT) is a complex system with multiple functions
including digestion and absorption of nutrients, protecting the host from a constant
presence of microorganisms, toxins, and other chemicals in the lumen. In newborn
calves, such functions and complexity are well known to be partially influenced by
exogenous nutritional and nonnutritional factors (i.e., bioactive compounds) that are
ingested with colostrum (Ontsouka et al., 2004). The latter effect is primarily associated
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with a direct influence on the maturation of the GIT in early life (Ontsouka et al., 2016).
Therefore, understanding the progression of the GIT to a mature state, and determining
what bioactive compounds in the colostrum have a predominant influence on this effect,
are high priorities to minimize diarrhea and improve welfare among young dairy calves.
However, studying early life maturation of the GIT can be challenging if this is done
primarily through analysis and characterization of postmortem or surgical collections of
GIT specimens. Such a challenge is more evident when repeated samplings over time on
the same animals are desired to observe changes over time as well as to minimize animal
variation. To overcome such challenges, we have previously proposed a novel technique
by isolating RNA from fecal samples of newborn dairy calves with the aim of obtaining
biological information on the GIT over time and using the same animals (Rosa et al.,
2018).
Results from that study suggested that isolating RNA from fecal samples for
subsequent quantitative reverse-transcription PCR analysis is a promising technique,
where we observed biological adaptations of the young ruminant GIT over time to a mild
diarrhea event, and these data were confirmed through blood biomarkers for
inflammation and oxidative stress (Rosa et al., 2018). Although this technique is
promising, several optimizations and validation steps are required to improve accuracy
and robustness. For instance, the migration of PMN across the intestinal epithelium is a
common pathological event of many mucosal inflammatory diseases (Brazil et al., 2010).
Because the fecal RNA method described by Rosa et al. (2018) discriminated primarily
against prokaryotic RNA (i.e., microbial RNA) but not immune cells, it is important to
understand the potential influence immune cells such as PMN might have during fecal
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RNA analysis. Additionally, the fecal RNA method is based on the premise that stool
samples contain a considerable number of epithelial cells (Nishizawa et al., 2005).
Consequently, evaluating the RNA enrichment from immune cells during fecal RNA
isolation is essential to understand the reliability of this method. Therefore, the objective
of this study was to evaluate the potential enrichment of RNA from PMN or GIT
epithelial cells during RNA isolation from fecal samples of neonatal dairy calves.
MATERIALS AND METHODS
Experimental design
The Institutional Animal Care and Use Committee of South Dakota State
University approved all procedures for this study (protocol no. A3958–01). During a
single sampling, fecal and blood samples were taken simultaneously from 8 neonatal
Holstein calves less than 3 wk old (14.9 ± 5.5 d of age at sampling ± SD) with a mean
fecal score [scale 1–4, 1: firm, well-formed (not hard); 4: liquid, splatters (Osorio et al.,
2012b)] of 2.0 ± 0.7 (mean ± SD) at sampling.
RNA isolation, cDNA synthesis, primer design and evaluation, and quantitative PCR
The fecal RNA isolation was conduct using the same protocol as explained in
Rosa et al. (2018). Briefly, ~200 mg of fecal sample was used for RNA isolation using a
Trizol (catalog no. 15596018, Ambion, Carlsbad, CA) based method along with the
RNeasy Plus Mini Kit (Qiagen, catalog no. 74134), following the manufacturer’s
instructions with some modifications. The RNA was eluted in 50 µL of RNase-free
water, and the quantity for all fecal samples was 378.8 ± 192.3 ng/µL and purity
(260/280 ratio) was 2.0 ± 0.1 determined via Nanodrop. In the case of PMN, the
complete PMN isolation protocol is presented in the Supplemental File (https://doi.org/
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10.3168/jds.2018-16074), and this protocol has been previously described by Osorio et
al. (2013). Briefly, 100 mL of blood was collected into evacuated tubes (10 mL, BD
Vacutainer, Becton Dickinson, Franklin Lakes, NJ) containing solution A of trisodium
citrate, citric acid, and dextrose. Samples were centrifuged at 600 × g for 30 min at 4°C.
The plasma, buffy coat, and approximately one-third of the red blood cells were
discarded. The remaining sample was purified through a series of washing and
centrifugation steps using deionized water, 5 × PBS, and 1 × PBS. An aliquot (20 µL)
obtained during the isolation process was used for PMN quantification and viability using
a granulocyte primary antibody (CH138A, Veterinary Microbiology and Pathology,
Washington State University, Pullman, WA) followed by a second antibody (Goat AntiMouse IgM, Human ads-PE, Southern Biotech, Birmingham, AL). All samples harvested
and used for analysis contained more than 80% PMN and had at least 90% viability.
After PMN isolation, RNA was extracted using the Trizol-based method along with the
RNeasy Plus Mini Kit. The RNA was eluted in 50 µL of RNase-free water, the quantity
for all PMN samples was 55.6 ± 32.7 ng/µL, and the purity was 1.9 ± 0.1. The RNA
integrity was assessed using the TapeStation (Agilent Technologies, Santa Clara, CA),
and the final RNA integrity number was 5.0 ± 2.6.
Details regarding primer sequences information and sources are presented in
Supplemental Table 2.1 (https://doi .org/10.3168/jds.2018-16074). The cDNA synthesis
and quantitative PCR were performed according to the protocol described by Rosa et al.
(2018) with some modifications. Each cDNA was synthesized by reverse transcription
using 500 and 100 ng of RNA for fecal and PMN samples, respectively. The quantitative
PCR reaction was performed in a QuantStudio 6 Flex Real Time PCR System (Applied
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Biosystems, Waltham, MA) in a MicroAmp Optical 384-well Reaction Plate (Applied
Biosystems). Relative mRNA expression of each gene was calculated based on a 6-point
relative standard curve plus the nontemplate control. Such a standard curve was
composited from all samples including cDNA from fecal and PMN. The internal control
genes (ICG) used in this experiment were golgin subfamily A, member 5 (GOLGA5),
oxysterol-binding protein-like 2 (OSBPL2), single-strand-selective monofunctional
uracil-DNA glycosylase 1 (SMUG1), β-2microglobulin (B2M), β-actin (ACTB),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and ribosomal protein 9 (RPS9).
Additionally, the ribosomal protein S15A (RPS15A) and peptidylprolyl isomerase A
(PPIA) were evaluated as potential ICG, but they were deemed to have low stability
across samples. Therefore, the geometric mean of the 7 ICG was used to normalize the
expression of the target genes on both types of samples (i.e., fecal and PMN). The
stability of the ICG was assessed using the geNorm software (Vandesompele et al.,
2002), with a favorable final pairwise variation of 0.19. The ribosomal protein S15A
(RPS15A) and peptidylprolyl isomerase A (PPIA) were evaluated as potential ICG, but
they were deemed to be unsuitable due to low stability across samples. Normalized gene
expression data were log-transformed before statistical analysis. The target genes were
selected based on their known specific association with either PMN or GIT epithelial
cells. In the case of PMN, the genes selected were myeloperoxidase (MPO) and selectinL (SELL), which are well-documented genes specific for PMN (Bionaz and Loor, 2008,
Moyes et al., 2009, Batistel et al., 2017), whereas aquaporin 3 (AQP3) (Ricanek et al.,
2015) and keratin 8 (KRT8) (Nishizawa et al., 2005) have been associated with epithelial
enterocytes.
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Statistical analysis
Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS
Institute Inc., Cary, NC). The model included type (PMN or GIT) as fixed effect and calf
as random. Statistical significance and tendencies were declared at P ≤ 0.05 and 0.05 ≤ P
≤ 0.10, respectively.
RESULTS AND DISCUSSION
Keratins are the largest family of cellular intermediate filament proteins and are
predominant in epithelial cells (Iyer et al., 2013), and among these, keratin 8 has been
associated with mammary epithelial cells and small intestinal mucosa (Moll et al., 1982,
Moll et al., 2008). In fact, the antibody against keratin 8 has been commonly used in
ruminants for cell purification of mammary epithelial cells from total milk cells
(Boutinaud et al., 2015). In contrast to epithelial cells, to the authors’ knowledge, the
expression of keratin 8 has not been reported in immune cells, and specifically PMN.
Accordingly, our results showed a substantially lower (P < 0.01) mRNA expression of
KRT8 in PMN in comparison to fecal RNA (Table 2.1), which suggests that the fecal
RNA samples contained a greater number of GIT epithelial cells. Interestingly, this is
supported by KRT8 having the greatest mRNA abundance in fecal RNA (Table 2.2), in
contrast to PMN, where SELL occupied the greatest mRNA abundance.
The genes MPO and SELL encode the enzyme myeloperoxidase and the cell
membrane L-selectin, respectively, and are essential for the normal cellular functions
associated with PMN cells in bovine (Paape et al., 2003). Myeloperoxidase is required by
PMN to produce reactive oxygen species responsible for the oxidative burst and
consequently killing capacity of PMN, whereas L-selectin allows PMN to recognize sites
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of infection or inflammation (Paape et al., 2003). Our results showed a lower (P = 0.01)
mRNA expression of SELL and a lack of amplification of MPO in fecal RNA samples in
comparison to the PMN samples (Table 2.1). Therefore, it is conceivable that the fecal
RNA samples contained small amounts of PMN mRNA transcripts, which is in
agreement with the greater expression of KRT8 in fecal RNA. Among the target genes in
this study, MPO had a greater efficiency than normal (>3; Table 2.2), which could be
associated with PCR amplification issues and indicates that the amplification,
unrealistically, had more than a 1-fold increase during every cycle amplification. The
authors associated this with the complete lack of amplification of MPO in fecal samples,
which might have skewed the slope and consequently the amplification efficiency.
Aquaporins are important cell transporters of water across biological membranes, and
aquaglyceroporins, a subtype of aquaporins, are capable of transport water, glycerol,
urea, and other small uncharged solutes across cell membranes (Rojek et al., 2008).
Aquaporin 3 (encoded by AQP3) is an aquaglyceroporin with a wide tissue distribution
including kidney, skin, esophagus, spleen, and small intestine among others (Rojek et al.,
2008). However, AQP3 is seldom reported to be expressed in PMN, and this
aquaglyceroporin has been suggested to play a role in the uptake of microbes during
phagocytosis (Marchini et al., 2003). In contrast to PMN, more data are available
confirming the expression of AQP3 in enterocytes and, furthermore, describing a role for
AQP3 during bacterial-induced diarrhea events in humans (Ricanek et al., 2015) and rats
(Zhao et al., 2014). We recently demonstrated the amplification of AQP3 in fecal RNA in
neonatal dairy calves, which also demonstrated a downregulation during a mild diarrhea
event (Rosa et al., 2018). Interestingly, the current results demonstrate a trend (P = 0.06)
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for a greater expression of AQP3 in PMN in comparison to fecal RNA. Due to the lack of
functional data on AQP3 in PMN, the latter effect remains unclear; however, the
expression of other aquaglyceroporins such as AQP9 have been reported in peripheral
leukocytes (Ishibashi et al., 1998).
Taking these data together, we observed a contrasting gene expression profile
between PMN and fecal RNA; whereas the greater mRNA expression of SELL in PMN
was expected, the greater mRNA expression of KRT8 in fecal RNA suggests that a
considerable amount of RNA originated from epithelial cells in fecal RNA. These data
provide new evidence on the reliability of the fecal RNA method; however, the data are
not conclusive and further research needs to be done to improve the accuracy and
robustness of this method while determining its limitations.
CONCLUSIONS
The data presented here are nuances in the refinement of the fecal RNA method to
study biological adaptations of the GIT of neonatal dairy calves through analysis of
transcriptional alterations. Our findings suggest that under nondiarrheic conditions RNA
isolated from stool samples of neonatal dairy calves will have a considerable number of
GIT epithelial cells, which confirms the reliability of this method under these conditions.
However, further research needs to be done to determine if the same effects are observed
during diarrhea or throughout the preweaning period of dairy calves.
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Table 2.1 Messenger RNA expression for specific gene markers for PMNL and GIT
epithelial cells in non-diarrheic neonatal dairy calves.
Gene
KRT8
SELL
MPO2
AQP3
1
2

Sample Type
Fecal
PMNL
2.43
-9.08
-5.58
-2.57
--0.36
-4.25
-2.45

Largest standard error of the mean.
Standard deviation for MPO in PMNL.

SEM1
0.52
0.70
2.31
0.70

P-value
< 0.01
0.01
-0.06
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Table 2.2 Slope, coefficient of determination of the standard curve (R2), efficiency of
amplification, and median cycle threshold (Ct) of quantitative reverse transcription
PCR.
Gene
All samples
SELL
AQP3
KRT8
MPO
PMNL samples
SELL
AQP3
KRT8
MPO
Fecal samples
KRT8
SELL
AQP3
MPO
1

Slope1

R2

E2

Ct3

mRNA abundance (%)4

-3.459
-3.171
-2.902
-2.076

0.98
0.99
0.99
0.95

1.95
2.07
2.21
3.03

21.90
29.93
32.41
32.19

99.38
0.48
0.13
0.00

-3.459
-3.171
-2.902
-2.076

0.98
0.99
0.99
0.95

1.95
2.07
2.21
3.03

21.46
29.05
33.12
31.87

99.55
0.44
0.01
0.00

-2.902
-3.459
-3.171
-2.076

0.99
0.98
0.99
0.95

2.21
1.95
2.07
3.03

27.03
29.91
35.60
N/A

75.15
24.74
0.10
0.00

Slope of the 6-point standard curve.
Efficiency of amplification [E=10(-1/slope)].
3
Ct = median cycle threshold which is defined as the number of cycles required for the
fluorescent signal to cross the threshold (i. e. exceed background level), and the amount of
target nucleic acid in the sample is inversely correlated to Ct cycles (i. e., the greater the
amount of target nucleic acid the lower the Ct cycles will be required).
4
mRNA abundance is calculated as a percentage of (1/E∆Ct) specific gene in the sum (1/E∆Ct)
all genes.
2
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Supplemental Table 2.1 Features of used primers for qPCR analysis. Hybridization
position, sequence, and amplicon size of primers for Bos taurus used to analyze gene
expression.
Gene
Symbol
GOLGA5

Primer1

Primers (5’-3’)

bp2

Source

F.1370

GAGCTACAGCAGCAAGTCAAAGTG

103

Moyes et al. (2009)

R.1472
F.198

CTTTAGACTGGAGTATTCGAGTAGCTTT
T
TGCCGTCACAGGCTTTGAC

100

Moyes et al. (2009)

R.297

CCATTACTTGCTGGTGTCCACAT

F.258

CAGCTACGTGACCCGCTACTG

117

Moyes et al. (2009)

R.374

CGGACTACACTCACTTCACCAAAG

F.908

TTGTCTCCTGCGACTTCAACA

103

Kadegowda et al. (2009)

R.1010

TCGTACCAGGAAATGAGCTTGAC

F.624

GCGTGGCTACAGCTTCACC

54

Kadegowda et al. (2009)

R.677

TTGATGTCACGGACGATTTC

F.99

TCCAGCGTCCTCCAAAGATT

86

Kadegowda et al. (2009)

R.184

CCCATACACATAGCAGTTCAGGTAA

F.192

CCTCGACCAAGAGCTGAAG

54

Bionaz and Loor (2007)

R.254

CCTCCAGACCTCACGTTTGTTC

F.405

GCAGCTTATGAGCAAGGTCGT

151

Bionaz and Loor (2007)

R.555

GCTCATCAGCAGATAGCGCTT

F.125

TCTGAGCACTGGAGAGAAAGGATTTG

88

Rosa et al. (2018)

R.212

GAAGTCACCACCCTGGCACATA

AQP3

F.398

GGGTTGTATTACGATGCGATCTG

81

Rosa et al. (2018)

MPO

R.478
F.1311

AAAGATGCCAGCTGTGCCATTG
AGCCATGGTCCAGATCATCAC

105

Batistel et al. (2017)

R.1415

ACCGAGTCGTTGTAGGAGCAGTA

F.588

CTCTGCTACACAGCTTCTTGTAAACC

104

Li et al. (2016)

R.691

CCGTAGTACCCCAAATCACAGTT

F. 1352

AGTGGCTACGCAGGTGGACT

181

Boutinaud et al. (2008)

R. 1532

CCGCAAGAGCCTTTCACTTG

OSBPL2

SMUG1

GAPDH

ACTB

B2M

RPS9

RPS15A

PPIA

SELL
KRT8
1
2

Primer direction (F – forward; R – reverse) and hybridization on the sequence.
Amplicon size in base pair (bp).
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CHAPTER 3. COMPARATIVE GENE EXPRESSION ANALYSIS OF
EPITHELIAL CELL MARKERS ACROSS GASTROINTESTINAL TISSUES
AND FECAL RNA ISOLATED FROM DAIRY CALVES

ABSTRACT
Our objective in this study was to compare the transcription of gene markers for
gastrointestinal tract (GIT) epithelial cells, fatty acid binding protein 2 (FABP2) and
cytokeratin 8 (KRT8), and tight junction complex genes (TJP1, CLDN1, CLDN4) in fecal
RNA against several GIT sections in dairy calves. Postmortem samples were collected
from ruminal epithelium, cecum, large intestine, duodenum, jejunum, ileum, and feces
from six healthy male Jersey calves (5 wk of age) for total RNA isolation. Normalized
gene expression data were log-transformed prior to statistical analysis using the Proc
Mixed of SAS. The expression of FABP2 was greater (P < 0.01) in the duodenum tissue
than in the GIT section associated with fermentation (i.e., rumen, large intestine, and
cecum). Within the small intestine, the mRNA expression of FABP2 was greater (P =
0.01) in duodenum than in jejunum, but not different than ileum. In fecal RNA, the
FABP2 expression was greater (P ≤ 0.03) than in the GIT section related to fermentation.
However, FABP2 was similar (P = 0.3) between fecal RNA and ileum. The expression of
KRT8 was greater (P ≤ 0.02) in cecum and large intestine than in rumen and jejunum.
Among the small intestine sections KRT8 was greater (P = 0.03) expressed in duodenum
than in jejunum. The fecal RNA had greater (P ≤ 0.02) expression of KRT8 than jejunum
and ileum. In contrast, the KRT8 expression in fecal was not different from the transcripts
observed in cecum and large intestine. Fecal RNA showed the greatest expression of the
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3 tight junctions proteins measured (P < 0.01) compared with the GIT tissues. However,
the expression of CLDN1 was higher in the ruminal tissue than in the fecal RNA (P =
0.03). The tight junctions TJP1, CLDN1, and CLDN4 were ubiquitously expressed (P ≥
0.5) through duodenum, jejunum, and ileum. Since the transcription of the genes specific
for GIT epithelial cells were significantly observed in the RNA isolated from feces, as
well as the genes encoding the tight junctions proteins, these preliminary data further
confirm that fecal RNA has a potential to be used as a tool to evaluate molecular
adaptations in the GIT of dairy calves.
Keywords: dairy calves; feces; RNA; intestinal health
INTRODUCTION
The gastrointestinal tract (GIT) or “gut” functionality is crucial for optimal animal
performance, including growth and milk yield in dairy cattle. Gut health has been
associated with animal welfare involving physiological aspects such as nutrient
absorption and energy metabolism, barrier function via mucosal secretion, interaction
with the gut microbiome (Kogut and Arsenault, 2016). The GIT has multiple functions
beyond the digestion and absorption of nutrients, for instance, regulation of the
physiological homeostasis that protects the host against exogenous stressors such as
harmful pathogens present in the lumen (Leaphart and Tepas, 2007). The GIT consists of
a symbiotic system which at equilibrium, involves bacteria-host interaction that regulates
intestinal barrier by a network of immune mechanisms including mucosal, pro- and antiinflammatory response (Hooper and Macpherson, 2010). Together, all these mechanisms
in the intestinal epithelium are the key to maintain the GIT equilibrium state, while
alterations in the gut barrier such as mucus degradation, and increased intestinal
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permeability can cause pro-inflammatory reactions and translocation of pathogens,
leading to gastrointestinal inflammatory conditions and possibly systemic inflammation
(Bischoff et al., 2014). Additionally, the GIT of neonatal animals undergoes
morphological and functional adaptation after birth, which is associated with overall
health. Regarding dairy calves, the neonatal stage is the period of high susceptibility to
infections, including pathogens that target the mucosal epithelium of the small intestine
(Malmuthuge et al., 2019). Therefore, understanding the interactions between these
diverse physiological features by gut health and how they affect the host can potentially
regulate animal production. Several experimental methods, including histology and
immunochemical staining, are used to investigate GIT physiology and pathology.
However, tissue preparation for histology requires invasive techniques, such as biopsy or
euthanasia (Bischoff et al., 2014). Besides the histological assays, molecular-based tools
(i.e., PCR and next-generation sequencing) have been used to investigate the biological
mechanisms underlying the gastrointestinal epithelium and barrier function early in life
of dairy calves (Liang et al., 2016, Malmuthuge and Guan, 2017), however the initial
acquire of samples relies on invasive method of tissue collections. A noninvasive method,
based on fecal RNA, to study the GIT in neonatal dairy calves through the isolation of
host-RNA from fecal samples for quantitative reverse-transcription PCR was described
by (Rosa et al., 2018). This study demonstrated that inflammatory transcripts present in
fecal RNA were associated with blood biomarkers of inflammation during the neonatal
stage of dairy calves undergoing a mild-diarrhea condition. Further improvements of this
method quantified genes in the feces of dairy calves associated with transcripts of
epithelial cells origin rather than from immune cells (Rosa and Osorio, 2019a). Taking
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together, these two approaches demonstrated that fecal RNA has the potential to be used
as a non-invasive tool to provide valuable information on GIT biological adaptations
during the preweaning period of dairy calves. Currently, no biomarkers have been
described as tools to evaluate GIT inflammatory condition or intestinal barrier function
through a non-invasive method such as feces analysis in dairy calves. Therefore, the
objective of this study was to evaluate well-known epithelial cell markers [i.e., fatty acid
binding protein 2 (FABP2); cytokeratin 8 [KRT8]), as well as regulatory proteins of the
intestinal permeability (i.e., tight junction proteins complex) across gastrointestinal
tissues and in the feces isolated from preweaned dairy calves.
MATERIALS AND METHODS
Animals and experimental design
All the protocols for this study (protocol no. 4747) were approved by the
Institutional Animal Care and Use Committee. Details for the original experimental
design have been published previously (Rosa et al., 2018). Briefly, 8 healthy male Jersey
neonatal calves were enrolled in a completely randomized design from birth to 5 wk of
age (i.e., preweaned period). Calves were housed in individual pens and fed twice daily
with pasteurized whole cow milk. Calves had ad libitum access to water and a starter
grain throughout the experiment.
Euthanasia and tissue collection
At the end of the trial, 6 preweaned calves (5 wk old) were euthanized by
rapid intravenous injection of a barbiturate (Somnasol euthanasia solution, Henry Schein)
to harvest gastrointestinal tissues (i.e., ruminal tissue, duodenum, jejunum, ileum, large
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intestine, and cecum) for gene expression analysis. Tissues were harvested using sterile
scalpel and forceps and were immediately cleaned with RNase decontamination solution
(RNaseZap®, AM9780, Thermo Fisher Scientific), quickly blotted with sterile gauze to
remove residual blood and snap-frozen in liquid nitrogen. Additionally, prior to the
euthanasia procedure, a fresh fecal sample was collected from each calf through rectum
stimulation into a 2 mL cryogenic vial (Corning®, Cat. # 430488), and immediately
snap-frozen in liquid nitrogen. All samples were then stored at -80°C until RNA
extraction.
RNA extraction and real-time quantitative PCR
The fecal RNA isolation was conduct using the same protocol, as described in
Rosa et al. (2018). Briefly, ~200 mg of fecal sample was utilized for RNA isolation using
a Trizol (Ambion, Cat. No. 15596018) based method along with the RNeasy Plus Mini
Kit (Qiagen, Cat. No. 74134), following the manufacturer’s instructions with some
modifications. The overall RNA quantity for all fecal samples was 428.38 ± 37.92 ng/µL,
and purity (260/280 ratio) was 1.97 ± 0.08 determined via Nanodrop. For the rumen and
gastrointestinal samples, 100mg of tissue was used for RNA isolation. And the RNA
quantity and purity determined via nanodrop was 1,868.53 ± 61.23 ng/µL and 2.09 ±
0.02, respectively.
Details regarding primer sequences information and sources are presented in
Tables 3.1 and 3.2. The complementary DNA (cDNA) synthesis and quantitative PCR
were performed according to the protocol described by Rosa et al. (2018) with some
modifications. Each cDNA was synthesized by reverse transcription using 500 ng and
100 ng of RNA for fecal and GIT tissues, respectively. The cDNA was then diluted 1:3
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(vol:vol) with DNase/RNase-free water. The qPCR reaction was performed in a
QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems, USA) in a
MicroAmp® Optical 384-well Reaction Plate (Applied Biosystems, USA). Relative
mRNA expression of each gene was calculated based on a six-point relative standard
curve plus the non-template control, which was composed of all cDNA samples from
fecal and GIT tissues. The internal control genes (ICG) used in this experiment were β-2microglobulin (B2M), β-actin (ACTB), glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), ribosomal protein 9 (RPS9), ribosomal protein S15A (RPS15A), and
peptidylprolyl isomerase A (PPIA). The stability of the ICG was assessed using the
geNorm software (Vandesompele et al., 2002), with a favorable final pairwise variation
of 0.21. Therefore, the geometric mean of the six ICGs was used to normalize the
expression of the target genes. The target genes evaluated in this study were the intestinal
epithelial cell marker FABP2, the keratin epithelial cell marker (KRT8), the tight junction
protein ZO-1 (TJP1), and the claudins 1, and 4, members of the tight junction complex
(CLDN1 and CLDN4, respectively).

Statistical analysis

Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS Institute,
Inc., Cary, NC, USA). The model included type of sample (fecal or GIT tissues) as a fixed
effect and calf as random. Statistical significance and tendencies were declared at P ≤ 0.05
and 0.05 ≤ P ≤ 0.10, respectively.
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RESULTS AND DISCUSSION
The GIT is considered to be the largest organ to play a key role in the immune
system, encompassing an intensive communication between the host and the gut
microbiome and digesta. The GIT represents a structural barrier, including vascular
endothelium, the epithelial cell lining, and the mucus layer, as well as, a functional
barrier, including immune molecules (i.e., immune cells, IgA secretion), antimicrobial
peptides secretion, inflammatory mediators, and cytokines production (Vighi et al.,
2008). The epithelial layer of the GIT presents a physical barrier that protects againts
exogenous pathogens and toxins entering the host. And such an epithelial layer consists
of cells connected by tight junction complexes. The tight junction protein complex is an
intercellular junction located in the apical membrane of the epithelial cells that connected
each cell, excluding the influx of pathogens and large molecules through the paracellular
pathway while allowing the diffusion of ions, water, and small molecules (Wells et al.,
2017). Tight junctions proteins include transmembrane proteins such as occludins and
claudins and intracellular proteins such as zonula occludens (ZO) proteins. In the
intestinal epithelium, the tight junctions proteins have been reported to decrease the
paracellular permeability (Angelow and Yu, 2009). Then, it is conceivable that such tight
junction proteins are essential during the development of gut-related diseases such as
celiac disease due to hyperpermeability of the intestinal epithelium (Bischoff et al.,
2014). Thus, tight junctions proteins are directly associated with intestinal epithelium
permeability (Van Itallie et al., 2009, Yu et al., 2014). In this study, we observed that the
expression of TJP1 is similar (P > 0.05) among the small intestine sections. TJP1
expression did not differ between the sections of the small intestine when compared to
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the cecum and large intestine (Figure 3.1). The TJP1 expression was similar (P = 0.12)
between the duodenum and ruminal tissue. However, the fecal samples had the greatest
(P < 0.01) expression of the TJP1 when compared with all the other small intestine
sections, cecum, large intestine, or ruminal tissue (Figure 3.1). The ruminal tissue had
greater (P ≤ 0.04) expression of the TJP1 than cecum, large intestine, jejunum, and
ileum. The claudins gene expression (CLDN1 and CLDN4) were similarly expressed (P >
0.05) in the duodenum, jejunum, or ileum (Figure 3.1). The CLDN1 expression was
greater (P = 0.03) in the ruminal tissue than in the fecal samples; however, the CLDN4
expression was greater (P < 0.01) in the fecal samples rather than in the ruminal tissue. In
fecal and ruminal samples, both CLDN1 and CLDN4 expression was greater (P ≤ 0.02)
when compared to cecum, large intestine, and the small intestine sections (Figure 3.1).
These findings are similar with other reports, where the expression of CLDN1 did not
differ among gastrointestinal regions of dairy calves during weaning transition from milk
to solid feed (Malmuthuge et al., 2013), as well as in dairy calves of 4 wk old (Walker et
al., 2015). Also, studies conducted in mice demonstrated that among the claudins (from
claudin-1 to- 19), the CLDN1, CLDN4, CLDN5, CLDN9, and CLDN10 were the lowest
expressed in the gastrointestinal regions (i.e., duodenum, jejunum, ileum, cecum, and
colon). Additionally, this study showed that there was no difference in the expression of
those claudins throughout the gut regions (Holmes et al., 2006). Several studies
demonstrated that tight junction complexes could be disrupted in the GIT due to
pathogenic infections either in humans, piglets, or calves, reducing the barrier function of
the epithelium (Guttman and Finlay, 2009, Jacobi et al., 2013, Walker et al., 2015). A
study conducted in neonatal lambs demonstrated that CLDN1 and CLDN4 expression in
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the ileum was altered due to early weaning (Li et al., 2018), which can be considered a
stressor triggering inflammation and intestinal barrier dysfunction. Inflammatory
responses including the production of pro-inflammatory cytokines (i.e., IFN-, TNF-,
and IL-1) can cause a dysregulation of tight junction proteins by altering their
expression, leading to increased paracellular permeability (Adams et al., 1993, Ma et al.,
2004, Al-Sadi and Ma, 2007). The tight junction proteins, TJP1 and CLDN,1 were
expressed at higher levels in the jejunum mucosal of heated stressed cows than control
(i.e., healthy) cows, which can be related with the relationship between inflammation and
GIT permeability (Koch et al. 2019). In the current study, the time of tissue collection
used for the RNA isolation was during the pre-weaning phase, when the dairy calves
were under the transition of being weaned from milk 1× d to an exclusively solid feed
diet, which is a stressor for dairy calves (Klotz and Heitmann, 2006).
The high tight junction expression in the ruminal tissue might be associated with
the morphological structure of the ruminal epithelium in contrast to the intestinal
epithelium. The rumen epithelium consists of stratified cells with leaf-like papillae that
increase the absorptive surface area. It is well established that the transport of nutrients
across the rumen epithelium is mediated by a gradient concentration difference (Sehested
et al., 1999, Shen et al., 2004). This rumen epithelium forms a permeability barrier
including tight junction proteins facing the ruminal lumen at the apical membrane of the
stratum granulosum. In contrast to the multilayered stratified squamous epithelium found in
the rumen, the small intestine, cecum, and large intestine consist of a simple columnar
epithelium that encompasses mucus-secreting cells resulting in a dense mucus layer (Steele et
al., 2016a). This mucus layer results in an extra layer of protection to the host within GIT
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regions, which does occur in the rumen (Graham and Simmons, 2005). The high abundance
of the tight junctions related genes (Table 3.3) within the ruminal samples can be attributed to
the morphological and physiological difference between the rumen and small intestine
epithelium. However, the high level of TJP1, CLDN1, and CLDN4 mRNA expression in the
fecal of preweaned calves observed in the current study` might be associated with epithelium
permeability of the rumen and lower gut. Moreover, these findings can be related with the
greater expression of inflammatory-related genes TNFA, NFKB1, IL1B, and TLR4 in the
feces of dairy calves at 4 and 5wk of age (Rosa et al. 2018), In that study, the calves were not
undergoing diarrhea (i.e., formed solid feces) during the time of the euthanasia and tissue
collection.

Keratins are the largest family of cellular intermediate filament proteins and are
predominant in epithelial cells (Iyer et al., 2013), and among the keratin family, keratin 8
has been associated with mammary epithelial cells and small intestinal mucosa (Moll et
al., 1982, Moll et al., 2008). Anti-keratin 8 antibody has been commonly used in
ruminants for cell purification of mammary epithelial cells from total milk cells
(Boutinaud et al., 2015). Keratin 8 has been used to measure exfoliated epithelial cells in
the feces of preterm infants with the aim to use fecal samples instead of invasive methods
to investigate GIT physiology (Kaeffer et al. 2007). Additionally, KRT8 expression was
used as a marker for intestinal epithelial cells in dairy cows (Koch et al., 2019). In the
current study, KRT8 expression was similar between the duodenum and fecal samples (P
= 0.18), as well as, KRT8 was similarly expressed in the cecum and large intestine when
compared to the feces mRNA (P = 0.30). However, the expression of KRT8 was greater
(P ≤ 0.02) in feces than in the jejunum and ileum tissues (Figure 3.2).
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Fatty acid binding proteins (FABP), which are small cytosolic proteins found in
enterocytes of both the small and large intestine are involved in the transportation and in
the metabolism of long-chain fatty acids, and such proteins have been used as a potential
marker for intestinal epithelial cells, since they are primarily produced by epithelial cells
of the small intestine and their release in blood circulation depends upon disease state of
the GIT (Funaoka et al., 2010, Bottasso Arias et al., 2015). Among the nine FABP
identified, the mRNA expression of FABP2 is highly expressed in the small intestine, and
it has been identified as a specific marker for the relative amount of epithelium in humans
(Levy et al., 2001). In livestock production, the FABP2 expression in the small intestine
of pigs was associated with intestinal permeability (Schroyen et al., 2012), as well as, the
loss of enterocytes was associated with a decrease in the FABP2 expression in the jejunal
mucosa of broiler chickens (Chen et al., 2015). In the present study (Figure 3.2), the
similar expression of FABP2 in the feces of calves compared to the expression in the
jejunum (P = 0.58) and ileum (P = 0.36), suggests that FABP2 gene can be used as a
biomarker of enterocytes when analyzed in feces.
Taken together, our findings demonstrated that there might be a difference in the
level of tight junction proteins between the rumen epithelium and intestinal epithelium of
dairy calves, and that can be attributed to the differential cell layers structure of the
epithelia. Regarding the specific epithelial cell markers, the low abundance of KRT8 and
FABP2 mRNA within ruminal samples (Table 3.3) is an indication that these markers are
highly specific to intestinal epithelial cells in ruminants, as previously demonstrated in
humans (Wiercinska-Drapalo et al., 2008, Gajda and Storch, 2015). Thus, this is in
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accordance with the greatest mRNA abundance of the FABP2 within the small intestine
samples evaluated (Table 3.3).
CONCLUSION
The similar mRNA expression of FABP2 and KRT8, known intestinal tissue
biomarkers, between fecal RNA and the lower GIT tissues indicates that to some extent,
the fecal RNA is a suitable proxy for lower GIT gene expression. The greater expression
of tight junctions genes (CLDN1, CLDN4, and TJP1) observed in the fecal transcripts in
comparison to GIT tissues was unexpected and warranted further exploration of this
effect in future research on fecal RNA. Based on the paramount importance of
gastrointestinal functionality to animal health and performance, having identified
biomarkers of GIT function and permeability in fecal RNA provide further evidence that
this technique can be a valuable asset to livestock research in gut health in the future.
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Table 3.1 Gene symbol, hybridization position, sequence, and amplicon size of primers
for Bos Taurus used to analyze gene expression.
Gene symbol

Primers1

Primers (5’ – 3’)

bp2

Source

GAPDH

F.908

TTGTCTCCTGCGACTTCAACA

103

(Kadegowda et

R. 1010

TCGTACCAGGAAATGAGCTTGAC

F.624

GCGTGGCTACAGCTTCACC

R.677

TTGATGTCACGGACGATTTC

F.99

TCCAGCGTCCTCCAAAGATT

R.184

CCCATACACATAGCAGTTCAGGTAA

F.192

CCTCGACCAAGAGCTGAAG

R.254

CCTCCAGACCTCACGTTTGTTC

F.405

GCAGCTTATGAGCAAGGTCGT

R.555

GCTCATCAGCAGATAGCGCTT

F.125

TCTGAGCACTGGAGAGAAAGGATTTG

R.212

GAAGTCACCACCCTGGCACATA

F.1352

AGTGGCTACGCAGGTGGACT

R.1532

CCGCAAGAGCCTTTCACTTG

F.371

GTGGCGAGATGGTCCAGACT

R.471

TCTGTGTTCTGGGCAATGCTC

F.480

GGCATCCTGCTGGGACTAATAG

R.579

CAGCCATCCGCATCTTCTGT

F.695

CCCCAGCCAGCAACTACGT

R.797

TCACAGATTGCAGTGAGCTCAGT

F.3748

GCACATAGGATCCCTGAACCA

R.3854

TGCTTCCGGTAGTACTCCTCATC

ACTB

B2M

RPS9

RPS15A

PPIA

KRT8

FABP2

CLDN1

CLDN4

TJP1
1
2

al., 2009)
54

(Kadegowda et
al., 2009)

86

(Kadegowda et
al., 2009)

54

(Kadegowda et
al., 2009)

151

(Bionaz and Loor,
2007)

88

(Rosa et al., 2018)

181

(Boutinaud et al.,
2008)

101

This manuscript

100

(Minuti et al.,
2015)

103

(Minuti et al.,
2015)

107

(Minuti et al.,
2015)

Primer direction (F – forward; R – reverse) and hybridization on the sequence.
Amplicon size in base pair (bp).
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Table 3.2 Sequencing results obtained from qPCR of Bos Taurus specific primers.
Gene

Sequence

FABP2

CATAGGTGTCACCAGATGATTTCCAAAAGGACGAGCACTGTTCCTGGAGCATCCCAAT
CACACAGATTTTTTGGGGCTCCTTGGTGGCCCTGTTTTGGTGAAGCTGAAGTATTCATT
GATGCTGATGCCTGACAAAGAGGTATGGGTTAACTGGGATTGTTTGGGAAGGAAATCG
GTTGGC

46

Table 3.3 Slope, efficiency (E) of amplification, coefficient of determination of the
standard curve (R2), median cycle threshold (Ct) of quantitative reverse-transcription PCR,
and relative mRNA abundance.
Gene
All Samples
FABP2
KRT8
CLDN1
CLDN4
TJP1
Fecal samples
FABP2
KRT8
CLDN1
CLDN4
TJP1
Small Intestine samples
FABP2
KRT8
CLDN1
CLDN4
TJP1
Rumen samples
FABP2
KRT8
CLDN1
CLDN4
TJP1
1

Slope1

E2

R3

Median Ct4

mRNA abundance %5

-3.006
-2.888
-3.290
-2.920
-3.258

2.15
2.22
2.01
2.20
2.03

0.99
0.98
0.99
0.98
0.99

21.84
22.77
25.30
24.09
22.77

66.54
18.45
1.79
3.39
9.83

-3.006
-2.888
-3.290
-2.920
-3.258

2.15
2.22
2.01
2.20
2.03

0.99
0.98
0.99
0.98
0.99

26.02
26.37
29.23
23.77
27.11

21.70
8.83
1.23
63.13
5.11

-3.006
-2.888
-3.290
-2.920
-3.258

2.15
2.22
2.01
2.20
2.03

0.99
0.98
0.99
0.98
0.99

17.86
22.18
24.92
24.70
22.89

95.25
2.07
0.39
0.28
2.00

-3.006
-2.888
-3.290
-2.920
-3.258

2.15
2.22
2.01
2.20
2.03

0.99
0.98
0.99
0.98
0.99

32.76
25.05
21.12
21.05
22.01

0.01
1.32
37.24
40.89
20.54

Slope of the 6-point standard curve.
Efficiency of amplification [E=10(-1/slope)].
3
coefficient of determination of the standard curve (R2)
4
Ct = median cycle threshold which is defined as the number of cycles required for the
fluorescent signal to cross the threshold (i. e. exceed background level), and the
amount of target nucleic acid in the sample is inversely correlated to Ct cycles (i. e.,
the greater the amount of target nucleic acid the lower the Ct cycles will be required).
5
mRNA abundance is calculated as a percentage of (1/E∆Ct) specific gene in the sum
(1/E∆Ct) all genes.
2
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Figure 3.1 Tight junction protein ZO-1 (TJP1), claudin 1 (CLDN1), and claudin 4
(CLDN4) relative mRNA expression (log2 scale) in rumen, gastrointestinal tract tissues,
and in total fecal RNA isolated from Jersey calves with 5 wk of age.
a,b,c,d
means without a common superscript differ (P ≤ 0.05).
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Figure 3.2 Fatty acid binding protein 2 (FABP2) and keratin 8 (KRT8) relative mRNA
expression (log2 scale) in rumen, gastrointestinal tract tissues, and in total fecal RNA
isolated from Jersey calves with 5 wk of age.
a,b,c,d
means without a common superscript differ (P ≤ 0.05).
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CHAPTER 4. EARLY LIFE FECAL MICROBIOTA TRANSPLANTATION
AFFECTS GROWTH PERFORMANCE, CALF SYSTEMIC, AND
POLYMORPHONUCLEAR LEUKOCYTES MRNA INDICATORS OF
INFLAMMATION AND LIVER FUNCTION IN NEONATAL DAIRY CALVES

ABSTRACT
The objective of this study was to evaluate the effects of early life fecal microbial
transplantation (FMT) on health and performance of neonatal dairy calves. The adult donor
was selected based on health and production records as well as fecal samples testing
negative for infectious pathogens. Sixteen healthy newborn Holstein calves (n=8/trt) were
used in a randomized complete block design and housed in individual hutches from birth to
7 wk of age. Calves were fed 2.8 L/d of antibiotic-free milk replacer 2×/d during wk 1 to 5,
1×/d on wk 6, and weaned at wk 7. Antibiotic-free starter and water were fed ad libitum.
Calves were assigned to either a baseline nutritional program (CON) or 1×/d inoculations
with 25 g of fecal donor material (FMT) mixed in the milk replacer from 8 to 12 d of age.
Blood samples were collected weekly for immunometabolic profiling and
polymorphonuclear leukocytes (PMNL) isolation for gene expression analysis. Data were
analyzed using the MIXED procedure of SAS. There was a trend (P = 0.09) for greater
body weight (50.8 vs 52.7 kg±0.7) in FMT calves. A TRT × Wk (P = 0.02) interaction was
observed in haptoglobin, that was reflected in a positive quadratic effect (P = 0.04) in FMT
calves but not in CON. A trend for a TRT × Wk (P = 0.06) interaction was observed in the
liver function biomarker paraoxonase, which resulted in greater (P < 0.01) paraoxonase in
FMT calves than CON at 3 wk of age. In albumin, the trend (P = 0.14) in TRT × Wk
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resulted in a trend (P ≤ 0.09) for lower albumin in FMT calves than CON at wk 1 and 2,
but albumin in FMT calves reached a similar concentration than CON by wk 3. A trend (P
= 0.07) for a TRT × Wk was observed in IL1B, which resulted in a contrasting positive
quadratic effect (P = 0.07) over time in FMT, while a linear increase (P = 0.07) was
observed in CON. The TRT × Wk (P = 0.09) in NFKB1 mRNA expression in PMNL was
associated with an upregulation (P = 0.03) in FMT calves than CON at wk 1 of age. These
results suggest that early life FMT in neonatal calves has positive effects in their neonatal
stage not only on growth performance but also in mediating the inflammatory response and
liver function.
Keywords: calves, fecal inoculation, microbiota
INTRODUCTION
The paradigm that the fetus develops within a sterile environment, born bacteriafree, and its first contact with bacteria only occurs after birth has been fundamentally
challenged (Elgin et al., 2016); the presence of microbiota was detected in newborn human
meconium (Jiménez et al., 2008), amniotic fluid and in the umbilical cord blood (Jimenez
et al., 2005), as well as in placental membrane (Aagaard et al., 2014, Collado et al., 2016).
Similar to humans, bacteria were detected in newborn calf meconium (Mayer et al., 2012)
and bovine uterus (Karstrup et al., 2017). Early life neonatal gut colonization can be
affected by prenatal factors including maternal microbiota, delivery mode, and by postnatal
factors such as colostrum intake, immune defense mechanisms, microbes adhesion, and
survival mechanisms as well as host luminal pH, diet, and antibiotic treatment
(Malmuthuge and Guan, 2017). Factors affecting the early life microbiome colonization of
the neonate gut can fundamentally challenge neonates and put them at risk for immune and
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metabolic disorders. It has been demonstrated that cesarean-born infants are deprived of the
vaginal microbiota inoculation as they pass through the birth canal and this can predisposed
them to long-term health consequences (Dominguez-Bello et al., 2016). Similarly, other
maternal microbiota in colostrum and milk have invaluable benefits in the health and
immunity of neonates across mammalian species.
In addition to the microbial colonization after birth, there is a gradual maturation of
gastrointestinal epithelial cells (GEC) that can be influenced by diet, length of gestation,
and antibiotic usage. The latter has been closely associated with a fundamental disruption
of the normal intestinal flora (i.e., dysbiosis), and consequently, linked with diseases in
both humans and animals (Francino, 2015). Therefore, early life gut colonization is a
crucial period for the adequate development of the neonate gut and immune system
(Hansen et al., 2012) and may have long-term health effects. Manipulation of gut
microbiota by feeding either probiotics or prebiotics has been studied in livestock animals
as strategies to improve production and health (Herfel et al., 2011, Vieira et al., 2013).
Enteric infections are the major causes of calf death during the first 4 wk of life
(Cho and Yoon, 2014). Developing methods to minimize calf diarrhea and improve gut
health during the preweaning period using alternative approaches to antibiotics is essential.
In humans, fecal microbial transplantation (FMT), which is the transfer of fecal
material from a healthy donor into the gastrointestinal tract (GIT) of a recipient with an
enteric condition (de Groot et al., 2017) has been used. FMT has been highly successful in
curing enteric diseases such as irritable bowel syndrome and Crohn’s disease in humans
(Ponte et al., 2015, Suskind et al., 2015). FMT has the capacity to shift microbial taxa and
to restore gut microbiota in humans. (Kelly et al., 2014). Currently, there are very few FMT
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studies in the animal science field, including companion animals (Pereira et al., 2018) and
livestock (Hu et al., 2018a) .
From a health standpoint, the host immune system and the commensal bacteria
present in the GIT need to be in equilibrium; otherwise, disruption of this balance may
cause dysbiosis, and an inflammatory response in the host might be triggered (Kamada et
al., 2013). However, the understanding of microbial communities and their interactions
with the host in neonatal calves during the preweaning in terms of gut health and
development is very limited. Therefore, we hypothesized that neonatal gut inoculation with
a healthy adult gut microbiota could improve GIT development and maturation early in
life. Thus, the objective of this study was to evaluate the effects of performing fecal
microbiota transplantation in neonatal dairy calves on growth and health performance, and
in the immune status.
MATERIALS AND METHODS
Experimental design
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota
State University (SDSU) approved all procedures for this study (protocol#A3958-01).
This study comprised of a pre-trial phase and a trial phase. The fecal material from the
selected cow donor was used in both phases of the study.
Donor Selection and fecal preparation
A group of 5 lactating Holstein cows was pre-selected from the herd at SDSU
Dairy Research and Training facility as potential donors under the following criteria: 1)
high milk yield production; 2) multiparous cows over 3 lactations ; 3) no clinical history of
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any disease (e.g., retained placenta, mastitis, etc.) during any lactation. Fecal samples were
collected from each cow, immediately kept on ice, and sent to the Animal Disease
Research and Diagnostic Laboratory at SDSU for analysis of infectious pathogens and
other risk factors. The stool testing included aerobic culture, fecal float for ova, and PCR
detection for the presence of Mycobacterium paratuberculosis, Salmonella, and
Cryptosporidium. From this group of pre-selected cows, one cow was negative for all the
fecal pathogens measured and had no clinical history of any disease during 5 lactations at
SDSU; therefore, this cow was designated as the donor. The final fecal material from the
donor was collected via rectum stimulation, immediately frozen in liquid nitrogen, and
stored at -80°C until the inoculation day.
Pre-trial phase: experimental design

Four healthy newborn Holstein calves from the SDSU Dairy Research and
Training facility were randomly selected if they met the following criteria: 1) between 2
and 4 weeks of age; 2) fecal score ≤ 2 [scale from 1 – 4, 1:well-formed-solid feces; 2:soft,
pudding-like; 3: runny, pancake batter; 4: liquid, splatters; (Osorio et al., 2012a)]. Calves
received one FMT inoculation via milk replacer in the morning feeding, and health records
were collected for 5 consecutive days. Calves received 25 g of fecal material from the
donor. The proposed 25 g of fecal material was derived from previous FMT performed in
humans [~70.55 kg BW of adult (Walpole et al., 2012)]. On the inoculation day, fecal
material was thawed in a warm (37°C) water bath as described by other studies (Hu et al.,
2018a, Wang et al., 2019). After the inoculation day, health checks were measured daily,
including fecal score (scale from 1 – 4), rectal temperature, and respiratory score [scale 1 –
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5, 1: normal; 2: runny nose; 3: heavy breathing; 4: cough moist; 5: cough dry; (Osorio et
al., 2012)]. There was no adverse effect on milk replacer intake, calf scours did not
increase, and the maximum rectal temperature observed was 39°C (Figure 4.1), whereas
there was no need to use anti-inflammatory medication for fever (not higher than 39°C).
Thus, no adverse effects were detected during the pre-trial phase, we proceeded with the
trial phase of this study.
Trial phase: experimental design and fecal microbiota inoculations
Sixteen healthy newborn Holstein calves (n = 8/TRT) from the SDSU Dairy
Research and Training facility were used for the trial phase in a completely randomized
design (CRD) experiment from birth to 7 weeks of age. Calves were enrolled in the
experiment if they fit the following criteria: calving difficulty < 3, single calf, and calf birth
weight ≥ 36 kg were. Calves were processed within 4 hours after birth; calf handling
included weighing, vaccinated with CALF-GUARD® (Bovine Rota-Coronavirus vaccine,
Zoetis, MI), navel disinfected with 7% tincture of iodine solution (First priority Inc., Elgin,
IL), and received 3.8 L of high-quality colostrum (> 60 mg/L) colostrum. Calves were
housed in individual hutches bedded with straw and had ad libitum access to water and
antibiotic-free starter grain (Calf 20 Nonmed®; 20% CP, Purina Animal Nutrition, MN)
throughout the experiment. Calves were randomly assigned to a control treatment (CON)
receiving 2.8 L of a commercial antibiotic-free milk replacer (Herd Maker®PB; Land
O’Lakes Animal Milk products, MN) twice daily, while calves subjected to the FMT
received the same regimen of milk replacer; however, during 8 to 12 d of age the morning
milk replacer was inoculated with 25 g fecal material from the donor. On the first
inoculation day, fecal material was thawed in a warm (37°C) water bath as described by
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other studies (Hu et al., 2018a, Wang et al., 2019), and subsequent homogenous aliquots
were kept at -20°C for the following 4 consecutive inoculations. After the 5th FMT
inoculation, calves received the same feeding program and management as CON calves.
During the 6 wk of age, all calves received milk replacer once a day and were completed
weaned at 7 wk of age.
Animal measurements
Growth performance, including body weight (BW) and withers height, were
recorded weekly before morning feeding. Health evaluations, including fecal score [scale 1
– 4], rectal temperature, and respiratory score [scale 1–5] were recorded daily throughout
the experiment. Individual intakes of milk replacer, starter grain, and water were measured
and recorded daily throughout the trial.
Blood sample collection
Blood samples were collected prior to morning feeding from the jugular vein using
20-gauge BD vacutainer needles (Becton Dickinson, Franklin Lakes, NJ). Samples were
collected into evacuated tubes (10 mL, BD Vacutainer®) containing either serum clot
activator or lithium heparin. The first blood sample was collected at 24 h after birth (i.e., 0
wk), and subsequent samples were taken weekly until 7 wk. After blood collection, tubes
with lithium heparin were placed on ice (4 °C), and tubes with clot activator were kept at
21°C (~30 min) until centrifugation. Serum and plasma were obtained by centrifugation of
clot activator and lithium heparin tubes, respectively, at 1,300 × g for 15 min at 4 °C.
Aliquots of serum and plasma were frozen (-80°C) until further analysis.
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Blood biomarkers
Blood samples were analyzed for energy metabolites [i.e., glucose, βhydroxybutyric acid (BHB)], muscle mass catabolism (i.e., urea and creatinine), liver
function [i.e., albumin, cholesterol, total bilirubin, gamma-glutamyl transferase (GGT),
paraoxonase (PON), glutamic-oxaloacetic transaminase (GOT)], inflammation [i.e.,
haptoglobin, ceruloplasmin, Interleukin (IL)-6, and IL-1β], and oxidative stress [i.e.,
reactive oxygen metabolites (ROM), ferric reducing antioxidant power (FRAP)] using kits
purchased from Instrumentation Laboratory (Lexington, MA) following the procedures
described previously (Trevisi et al., 2012, Batistel et al., 2016, Jacometo et al., 2016).
Polymorphonuclear leukocytes (PMNL) isolation

The PMNL were isolated based on procedures described by Rosa and Osorio
(2019b). Briefly, blood samples (~100 mL) were collected from the jugular vein prior to
morning feeding at 0, 1, 2, and 3 wk of age using a scalp vein butterfly (Excel
International, CAT# 26702) into evacuated tubes containing ACD solution A (BD, Cat#
268426) and mixed well by inversion and placed on ice until isolation. Samples were
centrifuged at 600 × g for 30 min at 4 °C. The plasma, buffy coat, and ~ one-third of the
red blood cells were discarded. The remaining sample was poured into a 50-mL conical
tube (Fisher Scientific, Pittsburgh, PA). Twenty-five milliliters of deionized water at 4 °C
was added to lyse the red blood cells (RBC), followed by addition of 5 mL of 5 × PBS at 4
°C to restore an iso-osmotic environment. Samples were centrifuged at 900 × for 10 min at
4°C, the supernatants were decanted, and the cell pellet was washed twice with 10 mL of 1
× PBS at 4°C. The cell suspension was centrifuged at 900 × for 5 min at 4°C, and the
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supernatants were discarded. The remaining RBC were lysed with 8 mL of ice-cold
deionized water, homogenized gently by inversion and 2 mL of 5 × PBS at 4°C was added.
The samples were centrifuged at 900 × for 5 min at 4°C, and the supernatant was discarded.
Subsequently, samples were washed twice using 10 mL of 1 × PBS at 4°C were performed,
followed by centrifugation 900 × for 5 min at 4°C. The PMNL pellet was homogenized
with 1.5 mL of 1 × PBS at 4°C, transferred to a 2-mL RNase-DNase-free microcentrifuge
tube and centrifuged at 6,000 × g (Sorvall Legend Microcentrifuge 21R) for 5 min at 4°C.
The final PMNL pellet was homogenized in 1 mL of Trizol reagent (Ambion, Carlsbad,
CA) and stored at -80 °C until further gene expression analysis.
Viability analysis of PMNL through flow cytometry
During the PMNL isolation process, an aliquot containing at least 500,000 cells
[counted via an automated cell counter (Countess II FL Cell counter from Life
Technologies)] was used for PMNL quantification and viability. The PMNL aliquots were
incubated for 30 min at 4°C with a primary antibody for granulocytes (CH138A,
Veterinary Microbiology and Pathology, Washington State University) followed by another
30 min incubation at 4°C with a secondary antibody (Goat Anti-Mouse IgM, human adsPE, Southern Biotech). Cells were fixed with 150 µL of 4% paraformaldehyde (SigmaAldrich) and preserved at 4°C until analysis. Flow cytometry data were acquired with the
Attune NxT cytometer (Attune® NxT Flow Cytometer, Invitrogen), and the panel with the
cell population of interest was analyzed using the Attune NxT cytometer software.
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RNA isolation, cDNA synthesis, and Quantitative PCR (qPCR)
Total RNA was extracted from blood PMNL using Trizol (Invitrogen, Cat# 15-596026) reagent in combination with the RNeasy® Plus Mini Kit (Qiagen, Cat#74134),
following the manufacturer’s instructions with some modifications. Briefly, the cell pellet
immersed in TRIzol was transferred to a 2-mL RNase-DNase-free O-ring tube, containing
one stainless steel bead, 5 mm (Qiagen, Cat#69989) and homogenized in a Beadbeater
(BioSpec Products, Cat#BSP74540) for 30s. After homogenization, the lysate was
transferred to a 2-mL RNase-DNase-free microtube and 200µL of Phenol:chloroform
(Invitrogen™, Cat#AM9730) at 4 °C was added in order to isolate the RNA from the
organic phase. After centrifugation at 13,000 x g for 15 min at 4 °C, the upper phase
supernatant was transferred into a new 2-mL RNase-DNase-free microtube. The total RNA
was purified RNeasy® Plus Mini Kit and eluted in 50 µL of RNase-free water. The RNA
quantity (111.13 ± 102.23 ng/µl; mean ± SD) and purity as 260/280 ratio (1.85 ± 0.15)
were determined using Nanodrop.
The complementary DNA (cDNA) synthesis was performed according to Bionaz
and Loor (2007). The cDNA was then diluted 1:4 with RNase-DNase-free water (HyClone,
UltraPure™, Cat#10977015). The qPCR was performed in a MicroAmp Optical 384-Well
Reaction Plate (Applied Biosystems, Grand Island, NY). Within each well, 4µL of diluted
cDNA combined with 6µL of a mixture composed of 5 µL 1×SYBR Green master mix
(Applied Biosystems, Woolston Warrington, UK), 0.4µL each of 10µM forward and
reverse primers, and 0.2 µL of DNase/RNase-free water. Three replicates were run for each
sample and a non-template control was run for each gene analyzed. The qPCR reaction was
conducted in QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems)
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following the conditions: 2 min at 50C, 10 min at 95C, and 40 cycles with 15s at 95C
followed by 1 min at 60C. A dissociation curve was performed (gradient from 95C to
60C to 95C for 15s) to check for amplicon quality.
For this study, relative mRNA expression of each gene was calculated based on a
six-point relative standard curve and the internal control genes (ICG) used were golgin
subfamily A, member 5 (GOLGA5), oxysterol-binding protein-like 2 (OSBPL2), and
single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1), which have
been previously used to normalize PMNL gene expression data (Moyes et al., 2010). The
geometric mean of the ICG was used to normalize the expression of the target genes. The
stability of the ICG was assessed using the geNorm software (Vandesompele et al., 2002)
with a favorable final pairwise variation of 0.20. The target genes measured within the
PMNL samples in this study are described in Table 4.1.
Statistical analysis
Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS Institute,
Inc., Cary, NC, USA). The model included treatment (TRT; CON and FMT), time (day or
week), and their interaction as fixed effects, and calf as a random effect. The autoregressive
(1) covariance structure was used for repeated measures for all parameters analyzed. Blood
metabolites and gene expression results were log-scale transformed if needed, in order to
comply with a normal distribution of residuals. Baseline samples taken at 24 h after
colostrum intake or 0 wk were used as a covariate in the model if they were significant (P <
0.05). A priori orthogonal contrasts were used to determine linear and quadratic effects
over time whenever at least a trend (P ≤ 0.10) for a treatment × week (TRT × Week) was
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observed. Statistical significance and tendencies were declared at P ≤ 0.05 and P ≤ 0.15,
respectively.
RESULTS
Growth performance and health
Main effects of TRT, time, and their interaction for growth performance and health
parameters are presented in Figure 4.2. There was a trend (P = 0.09) for greater BW (50.8
vs 52.7 kg±0.7) in FMT calves in comparison to CON. Similarly, there was a trend (P =
0.13) for greater WH in FMT (82.6 vs 83.8 kg ± 0.49) calves in comparison to CON.
Starter intake and average daily gain (ADG) were not affected by treatment effects;
however, they increased over time (P < 0.01) (Figure 4.3). Fecal scores and rectal
temperature were not affected (P ≤ 0.65) by FMT inoculation (Figure 4.4).
Blood biomarkers
Main effects of treatment, time, and their interaction for blood biomarkers of
energy metabolism, inflammation, liver function, and oxidative stress are presented in
Table 4.2.
Energy metabolism. The blood concentrations of glucose, BHBA, and creatinine
were not affected (P ≥ 0.20) by treatment (Table 4.2). A trend (P = 0.07) for a TRT × Week
was observed for urea.
Inflammation. There was a TRT × Week (P = 0.02) for haptoglobin, and this was
reflected by a positive quadratic (P = 0.04) effect observed on FMT treatment only, and
this was particularly evident at 2 wk, where FMT calves had greater (P = 0.01)
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concentration of haptoglobin when compared with CON calves (Figure 4.2). Similarly, a
trend for a TRT × Week (P = 0.07) was observed for IL-1 in blood (Figure 4.5), which
was reflected in a trend (P = 0.07) for a positive quadratic effect in FMT calves only, while
IL-1 I in CON tended (P = 0.07) to have a linear increase over time (Figure 4.5).
Ceruloplasmin was not affected (P = 0.51) by treatment effects. Blood IL-6 decrease (P <
0.01) gradually regardless of treatment was observed in blood IL6 over time (Table 4.2).
Liver function. There was a TRT × Week (P ≤ 0.14) for albumin, paraoxonase,
and total bilirubin. In the case of albumin, FMT calves tended (P ≤ 0.10) to have lower
albumin than CON at 1 and 2 wk of age; however, albumin was similar (P = 0.89) in both
groups by 3 wk (Figure 4.5). The latter was reflected in a greater rate of increase in
albumin concentration from wk 1 to 3 in FMT calves than CON (6.2% vs. 3.5%,
respectively). The TRT × Week (P = 0.06) in paraoxonase, which was explained by greater
(P < 0.01) paraoxonase in FMT calves than CON at 3 wk of age (Figure 4.5). There was a
trend for a TRT × week (P = 0.13) effect on total bilirubin, which can be explained by a
trend (P = 0.06) for lower total bilirubin in FMT calves at 1 wk of age when compared to
CON. Cholesterol, GOT, and GGT were not affected (P ≥ 0.25) by treatment effects.
Cholesterol and GOT increased (P < 0.01) over time, while GGT decreased (P < 0.01;
Table 4.2).
Oxidative stress. No effects (P ≥ 0.20) were observed for ROM and FRAP (Table
4.2).
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PMNL gene expression
Pro-inflammatory signaling and cell adhesion genes. Main effects of treatment,
time, and their interaction on mRNA expression in PMNL are reported in figure 4.6.
Overall, FMT calves had greater (P = 0.03) expression of ZBP1 than CON, and to a
lesser extent, FMT calves tended (P = 0.12) to have greater NFKB1 than CON. The
expression of STAT3 and SELL was not affected by treatment.
Pathogen recognition and cytokines. Main effects of treatment, time, and their
interaction on mRNA expression in PMNL are reported in figure 4.7. A trend for a TRT ×
week (P = 0.11) was observed for the TLR2 expression, which was reflected on a trend (P
= 0.11) for greater TLR2 in FMT calves than CON at 2 wk of age. Overall, IL8
expression decreased (P = 0.01) over time in all animals. The expression of TLR4 and
IL1B was not affected by treatment or time.
DISCUSSION
Animal Performance
We reported for the first time the use of FMT in neonatal dairy calves. The
procedure proved to be safe with no adverse effects, including no milk refusal, no
increase in rectal temperature, or respiratory score in FMT animals. These results are in
agreement with other FMT studies in swine and companion animals (Xiao et al., 2017,
Pereira et al., 2018). Regarding gastrointestinal signs, no severe diarrhea (FS = 4) was
observed during the trial, and the fecal score was not affected by FMT, suggesting that
FMT can be a safe procedure. However, further studies are needed to confirm this lack of
effect on fecal scores.
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To our knowledge, our study is the first experiment in dairy calves that attempted
to evaluate the effects of performing FMT on calf performance (i.e., body conformation
and feed intake). The tendency for greater BW and WH observed in the treated calves
suggest that FMT can enhance growth performance. In contrast to BW and WH, the lack
of treatment effects on starter intake suggests that FMT might improve feed efficiency
and animal performance. Our findings regarding animal performance are in accordance
with other studies that performed FMT in young livestock animals. For instance, Hu et al.
(2018b) orally inoculated newborn pigs from day 1 to day 11 of life with a fecal
suspension from a healthy donor, and the recipient piglets had greater average daily gain
than the control piglets. Also, the incidence of diarrhea decreased in the FMT group when
compared with the control piglets. Additionally, fecal inoculations from a highly feedefficient donor chicken into broiler chickens early in life tended to increase feed intake
and body weight in the FMT recipients chickens (Siegerstetter et al. 2018).
Biomarkers of inflammation and liver function
The acute phase response is triggered by an inflammatory condition, and it is
regulated by several cytokines such as IL1- which is produced by immune cells (i.e.,
dendritic cells and macrophages) present in the inflamed tissue (Murata et al., 2004). In
the small intestine, epithelial cells in the inner surface (i.e., enterocytes) can release
cytokines (e.g., IL-6) upon inflammation, which stimulates the production of the acute
phase proteins (APPs) by hepatocytes and other tissues (Pritts et al., 2002). In the
neonatal liver, the synthesis of APPs can be related to liver maturation rather than a
disease-related process (Orro et al., 2008), which makes the interpretation of APPs in
neonates cumbersome. Regardless of treatment, the high IL-6 concentration after birth
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could be attributed to an activation of the immune system due to colostrum ingestion and
adaptation to an extrauterine environment. Then, the decline in IL-6 over time could be
related to the consolidation of the active immunity in the newborn calves, which agrees
with the results observed by Jacometo et al. (2016). In the current study, the greater
haptoglobin in FMT calves at 2 wk of age confirms that fecal inoculations between 8 and
12 d of age challenged the host to some extent. This is in agreement with Bertoni et al.
(2009), where they reported that haptoglobin greater than 0.2 g/L in blood of neonatal
calves is associated with an inflammatory condition. However, the haptoglobin
concentration in FMT calves was modest when compared with other studies, where dairy
calves were challenged with an infection (Haptoglobin = 1.23g/L) or undergoing a mild
diarrhea (Haptoglobin = 0.35g/L) (Silva et al., 2011, Rosa et al., 2018). The fact that IL1β in FMT calves have a similar pattern as haptoglobin at 2 wk of age concomitantly with
the lack of FMT effect on IL-6 over time, is an indicative of a local inflammatory
condition rather than systemic inflammation.
The anti-inflammatory enzyme paraoxonase (PON) blood levels increased over
time healthy neonatal calves; in calves of 7 d of age average concentration of PON in
blood was 8.9±5.2 U/mL (mean±SD) and in calves with 28 d of age the concentration
was 42.8±14.8 U/mL (Giordano et al. (2013). However, when calves demonstrated a
degree of inflammation (i.e., diarrhea or respiratory disease), the average PON observed
in the blood of sick calves was 3.7±1.4 U/mL at 7 d of age and 24.5±13.4 U/mL at 28 d
of age. Thus, there is a significant difference in PON concentration in healthy vs. sick
(i.e., inflammatory condition) neonatal calves.
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The hepatic metabolic activity in neonatal calves is lower than the adult ruminant
(Baldwin et al. 2004). This can be partially explained by the alterations in the
metabolizable substrates by the liver from pre-ruminant to ruminant (i.e., glucose and
fatty acids vs. short-chain fatty acids [SCFA] due to rumen development). In this context,
the shift from glucose intestinal absorption during pre-weaning period to SCFA, ketones,
and microbial protein absorption in an adult ruminant lead to changes in the hepatic
function and energy metabolism during the transition from pre- to- ruminant, including
the reduction in enzyme activity of glucose oxidation in the liver (Baldwin et al., 2004).
Thereby, the synthesis of proteins, including the acute phase (i.e., albumin, paraoxonase)
in the liver during the neonatal stage can be associated with liver development. This can
be attributed to metabolic adaptations and immune stimulation leading to maturational
changes of the hepatic organ during the pre-weaning phase (Orro et al., 2008, Giordano et
al., 2013).
There is also an increase in blood albumin and paraoxonase from birth to weaning
(i.e., 5wk of age) of dairy calves (Jacometo et al., 2016, Rosa et al., 2018). Others have
reported that decreased liver function can be associated with albumin less than 30 g/L in
blood (Bertoni et al., 2009). Therefore, the greater paraoxonase concentration in FMT
calves suggests a positive effect on the liver maturation. Similarly, the greater rate of
increase for albumin in FMT calves suggests a positive effect of fecal microbial
inoculations in liver function.
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PMNL gene expression
The ZBP1 gene encodes the protein Z-DNA binding protein 1, which plays a role
in sensing cell death and microbial pathogens, including viruses that are not recognized
by TLR2 or TLR4 (Kuriakose and Kanneganti, 2018). Overall, the increase in ZBP1
expression between birth and 7 d of age could have been linked with a transient
inflammatory response triggered by colostrum intake and other conditions such as
environmental pathogens exposure during the first wk of life. However, the decreased in
its expression after FMT (8-12 d of age) can be attributed to the regulation of the innate
immune response, since the release of pro-inflammatory cytokines upon TLR pathway is
initiated is essential for neutrophil pathogen recognition and activation (Sabroe et al.,
2005, Takaoka et al., 2007), which can be associated with the lack of acute or systemic
inflammation (i.e., unresponsive IL-6 to FMT effect) during the trial.
Although calves in the FMT group tended to have greater NFKB1 expression, that
response was not associated with an upregulation of pro-inflammatory pathways as
indicated by the lack of response to FMT in STAT3, SELL, TLR4, IL1B, and IL8
expression. Taken together, these results seem to support that fecal inoculations starting
at 8 d of age triggered a mild to moderate inflammatory response that allowed FMT
calves to maintain a higher expression of the activators of the immune system and further
upregulation of pro-inflammatory signaling genes was not warranted. Similarly, lower
expression of pro-inflammatory mediators, including NFKB1 and MYD88, low IL1B
expression, and lack of change in the expression of TNFA in PMNL isolated was seen in
neonatal dairy calves in response mineral supplementation (Jacometo et al. 2015).
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CONCLUSIONS
This study demonstrated that early life fecal microbiota transplantation into
neonatal dairy calves is a relatively safe method and can influence calf growth and
development. Taken together, these data demonstrated that FMT performed using fecal
material from a selected donor (elite cow of the herd) improved the hepatic maturation
due to the increase in acute phase protein synthesis during calf neonatal stage. Based on
the pattern of the biomarkers of inflammation in calves subjected to FMT, there is
evidence that FMT is less likely to cause an acute or systemic inflammatory response,
and perhaps it can modulate the transition from a passive immunity (i.e., colostrum) to an
active immunity in neonatal calves. The precise biological mechanisms being altered by
fecal microbiota inoculations in neonatal calves remains to be determined; however, the
evidence for such alterations is underpinned by the seemly improved growth in FMT
calves. Additional research in this area is needed to confirm our results and shed light on
putative biological mechanisms on the FMT response observed in the current study.
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Table 4.1 Genes selected for transcript profiling in bovine polymorphonuclear leukocytes
(PMNL).
Gene Name

Symbol

Function

NF-KB1

NF-kappa-B is a pleiotropic transcription factor present in
almost all cell types and is the endpoint of a series of signal
transduction events that are initiated by a vast array of
stimuli related to many biological processes such as
inflammation, immunity, differentiation, cell growth,
tumorigenesis, and apoptosis.

STAT3

This protein is activated through phosphorylation in
response to various cytokines and growth factors including
IFNs, EGF, IL5, IL6, HGF, LIF, and BMP2. This protein
mediates the expression of a variety of genes in response to
cell stimuli, and thus plays a key role in many cellular
processes such as cell growth and apoptosis.

SELL

This gene encodes a cell surface adhesion molecule that
belongs to a family of adhesion/homing receptors. The
gene product is required for binding and subsequent rolling
of leucocytes on endothelial cells, facilitating their
migration into secondary lymphoid organs and
inflammation sites.

IL1B

Produced by activated macrophages, IL-1 stimulates
thymocyte proliferation by inducing IL-2 release, B-cell
maturation and proliferation, and fibroblast growth factor
activity. Potent proinflammatory cytokine.

Z-DNA Binding Protein 1

ZBP1

This gene encodes a Z-DNA binding protein. The encoded
protein plays a role in the innate immune response by
binding to foreign DNA and inducing type-I interferon
production.

Toll-Like Receptor 2

TLR2

The protein encoded by this gene is a member of the Tolllike receptor (TLR) family which plays a fundamental role
in pathogen recognition and activation of innate immunity.

TLR4

The protein encoded by this gene is a member of the Tolllike receptor (TLR) family which plays a fundamental role
in pathogen recognition and activation of innate immunity.
This receptor has been implicated in signal transduction
events induced by lipopolysaccharide (LPS) found in most
gram-negative bacteria. Mutations in this gene have been
associated with differences in LPS responsiveness

IL8

Also, referred to as CXCL8 (C-X-C Motif Chemokine
Ligand 8). It is a chemotactic factor that attracts
neutrophils, basophils, and T-cells, but not monocytes. It is
also involved in neutrophil activation. It is released from
several cell types in response to an inflammatory stimulus.

Nuclear Factor of Kappa Light
Polypeptide Gene Enhancer In
B-Cells 1

Signal Transducer and Activator
of Transcription 3 (Acute-Phase
Response Factor)

Leukocyte-Endothelial Cell
Adhesion Molecule 1

Interleukin 1 B

Toll-Like Receptor 4

Interleukin 8
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Table 4.2 Blood immunometabolic biomarkers during neonatal period in Holstein dairy
calves under a conventional nutritional program (CTR) or subjected to five days of fecal
microbiota inoculations (FMT) within antibiotic-free milk replacer.
Group2
Parameter1

P-value4
SEM3

TRT

Week

TRT × week

5.69

0.34

0.33

0.04

0.28

0.09

0.07

0.01

0.20

0.36

0.28

Creatinine, mol/L

94.65

91.75

4.41

0.65

0.03

0.72

Urea, mmol/L

2.98

2.74

0.16

0.29

0.01

0.07

Haptoglobin, g/L

0.191

0.212

0.01

0.24

0.06

0.02

Ceruloplasmin, mol/L

1.82

1.95

0.13

0.51

0.38

0.29

IL1- (Log2) pg/mL

3.69

3.67

0.39

0.98

0.26

0.07

IL-6, (Log2) pg/mL

8.17

7.96

0.20

0.48

< 0.01

0.68

Albumin, g/L

30.61

30.03

0.29

0.18

< 0.01

0.14

Paraoxonase, U/mL

34.50

40.56

2.19

0.07

< 0.01

0.06

Total bilirubin, mol/L

4.67

6.30

0.97

0.26

< 0.01

0.13

Cholesterol, mmol/L

CTR

FMT

Glucose, mmol/L

6.23

BHBA5, mmol/L

Energy metabolism

Inflammation

Liver function

2.68

2.40

0.17

0.25

< 0.01

0.31

6

5.76

5.89

0.11

0.42

< 0.01

0.71

GGT7, U/L

458.42

418.14

87.38

0.76

< 0.01

0.16

12.06

12.09

0.60

0.98

0.23

0.20

160.45

149.64

7.79

0.36

0.46

0.34

GOT (Log2), U/L

Oxidative Stress
ROM8, mg H2O2/100 mL
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Figure 4.1 Rectal temperature (°C) after a fecal microbiota transplantation (FMT) within
antibiotic-free milk replacer into neonatal Holstein calves during a pre-trial phase of 4
days.
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Figure 4.2 Growth performance from birth (week 1 f age) to weaning (7 weeks of age) of
Holstein dairy calves under a conventional nutritional program (Control) or subjected to
five days of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer
from 8 d to 12 days of age. The P-values for main effects of treatment (TRT) and week,
and their interaction (TRT x Week) are shown in each plot. Values are means with
standard errors represented by vertical bars.
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Figure 4.3 Performance parameters from birth to weaning of Holstein dairy calves under
a conventional nutritional program (Control) or subjected to five days of fecal microbiota
inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 days of age. The
P-values for main effects of treatment (TRT) and week or day, and their interaction (TRT
x Week; TRT x Day) are shown in each plot. Values are means with standard errors
represented by vertical bars.
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Figure 4.4 Health parameters from birth to weaning of Holstein dairy calves under a
conventional nutritional program (Control) or subjected to five days of fecal microbiota
inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 days of age. The
P-values for main effects of treatment (TRT) and day, and their interaction (TRT x Day)
are shown in each plot. Values are means with standard errors represented by vertical
bars.
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Figure 4.5 Inflammatory [Haptoglobin and interleukin 1 beta (IL1-β)] and liver function
biomarkers [albumin and paraoxonase) during the neonatal period in Holstein dairy
calves under a conventional nutritional program (Control) or subjected to five days of
fecal microbiota inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12
days of age. The P-values for main effects of treatment (TRT) and week, and their
interaction (TRT x Week) are shown in each plot. The TRT x Week effect (P ≤ 0.10)
were further analyzed through orthogonal contrast in order to determine linear (L) and
quadratic (Q) effects. A significant difference (P < 0.05) between treatments in a specific
time point was denoted by an asterisk (*). Values are means, with standard errors
represented by vertical bars.
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Figure 4.6 Expression of genes related to pro-inflammatory signaling cascade (ZBP1,
NFKB1, STAT3) and cell adhesion (SELL) in polymorphonuclear leukocytes (PMNL) of
dairy calves under a conventional nutritional program (Control) or subjected to five days
of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12
days of age. The P-values for main effect of treatment (TRT) and week and TRT*Week
are shown. Data before week 1 of age are from samples 24 hours after birth (baseline).
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Figure 4.7 Expression of genes associated with pathogen recognition (TLR2 and TLR4)
and pro-inflammatory cytokines (IL1B and IL8) in polymorphonuclear leukocytes
(PMNL) of dairy calves under a conventional nutritional program (Control) or subjected
to five days of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer
from 8 d to 12 days of age. The P-values for main effect of treatment (TRT) and week
and TRT*Week are shown. Data before week 1 of age are from samples 24 hours after
birth (baseline).
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OVERALL SUMMARY AND CONCLUSION
The research presented accomplished the overall objective, which was: a) to
validate and optimize a non-invasive method to investigate transcriptomic changes in the
gastrointestinal tract of neonatal dairy calves; b) to evaluate the effects of an early life
fecal microbiota transplant on growth and health performance on neonatal dairy calves.
The results in Chapter 2 indicated that RNA isolated from fecal samples contain a low
number of immune cells such as PMNL and further confirms the signal observed in genes
related to inflammation in fecal samples. Interestingly, the mRNA abundance of 99.55%
detected for the gene marker for immune cells SELL within the PMNL samples, in
contrast to the 75.15% abundance of KRT8 gene marker for epithelial cells within fecal
samples provided new insights on the fecal RNA reliability.
The results in Chapter 3 indicated that the tight junction complex might affect the
rumen epithelia in a different manner than the intestinal epithelia based on the contrasting
expression between ruminal tissue and intestinal tissues for the genes TJP1, CLDN1, and
CLDN4. Based on the greater expression of genes markers of epithelial cells, FABP2 and
KRT8 observed in the fecal samples together with the high abundance of CLDN4 mRNA
in feces further confirm the reliability of transcripts identified in feces with the host. The
gene expression performed across studies at different fecal scores levels suggests that
fecal RNA could be a robust technique that can be utilized to investigate physiological
alterations in non-diarrheic and diarrheic animals.
Regarding the FMT study, the findings from Chapter 4, demonstrated that early
life inoculations of fecal material from selected donors into neonatal calves did not
induce scouring or produced a strong inflammatory condition. Transient and mild
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increases in pro-inflammatory blood biomarkers, haptoglobin, and IL-1B, suggests that
fecal inoculations stimulate the innate immune response in neonatal calves. In addition,
the greater rates of increase in albumin and paraoxonase over time in FMT calves provide
evidence for an improved hepatic maturation effect on calves subjected to FMT.
The gene expression in the PMNL samples in Chapter 4 indicated that all animals,
including control and FMT calves, experienced an inflammatory condition at birth, which
dwindled over time. Moreover, the lack of effect of FMT on PMNL gene expression
confirms that such fecal inoculations did not produce an adverse inflammatory condition
in FMT calves.
The linear increase in starter (grain pellets) intake over time indicated that FMT
did not present an adverse effect on solid feed intake. The trend observed on BW and
WH for greater overall growth on FMT calves provides further evidence for the
beneficial effects of altering the gut microbiota of neonatal dairy calves.
Overall, our studies provided new insights on the utilization of fecal material to
not only improve our understanding of the GIT maturation in neonatal dairy calves but
perhaps its modification through FMT to enhance growth and welfare. Although our
results on the early life fecal microbiota transplantation into neonatal dairy calves
demonstrated positive effects on calf growth and performance, further research is needed
to investigate the mechanisms through which the immature GIT in neonates interacts with
the newly colonizing microbiota and correlate these effects with neonatal immunity and
performance.
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An approach such as FMT can be used as a method to manipulate the early life
GIT microbiota colonization of neonates to prime a more desirable host-microbiota
development and interaction so that neonates can better face the challenges during the
first weeks of life. For instance, within a given herd, dairy cows could be selected as elite
donors, and based on fecal screening and production records (similar to our study), each
farm can have fecal samples stored for further inoculations into the newborn calves. In
this way, neonates would acquire adapted and targeted microbiota (i.e., from the same
environment) from high producing and healthy cows, priming the GIT colonization and
development during the neonatal stage.
The inability to take sequential GIT samples over time using a traditional
postmortem sample collection approach is a limitation to account for the inherent animal
variation and may restrict the accurate development of models and mechanisms occurring
over time during enteric infections. Like any other biological process, enteric infections
such as diarrhea are a dynamic process where time is an important factor. Over time,
infections in the GIT can lead to the disruption of tight junctions between enterocytes in
the epithelial barrier, compromising the electrolytes balance, thus, increasing the flux of
these into the intestinal lumen. The molecular changes underpinning this phenomenon
occur in the early phases leading to diarrhea. In our research, RNA isolated from feces of
neonatal dairy calves is proposed as a proxy for GIT gene expression to investigate the
molecular adaptations to pathogenic infections of the GIT, which could lead to uncover
key regulatory mechanisms employed by pathogens, which can, in turn, can become
therapeutic targets based on the new knowledge generate from the fecal RNA method.
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